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Diabetes is one of the most common chronic diseases in the world. Diabetic patients are also 
more susceptible to develop additional comorbidities over time even causing death. This makes 
it essential to identify the risk of developing comorbidities as early as possible for effective 
diabetes management and to reduce the burden on healthcare system.  Large volumes of clinical 
data which has been collected over the years has potential to be translated into meaningful 
information to enable healthcare professionals gain insights into diabetic patient comorbidities.  
This research has two key contributions. First, an interactive diabetes dashboard is developed 
in which the data is integrated and shown in the form of visually appealing charts, graphs and 
tables. The dashboard displays aggregated results with drilldown capabilities to allow 
navigation at finer granularities of various metrics. Second, predictive models are built to 
forecast the likelihood of one of the three common comorbidities for diabetic patients – Benign 
Hypertension, Congestive Heart Failure, and Acute Renal Failure. The models use advanced 
data mining algorithms such as Logistic Regression, Neural Network, CHAID, Bayesian 
Network, Random Forest and Ensemble. Results from these models are also incorporated into 
an interactive assessment tool that has the ability to take user input and predict the likelihood 
of one of these comorbidities.  Northern Health (NH) dataset consisting exclusively of diabetic 
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Chapter 1  
Introduction 
Diabetes, or Diabetes Mellitus, is a chronic disease in which the body cannot either 
produce or utilize insulin. Insulin is a hormone which controls the amount of glucose 
(sugar) in blood. Elevated blood sugar levels may lead to damage of vital organs and can 
be fatal. There are three main types of Diabetes Mellitus [1]:  
1. Type 1 diabetes (T1D) - occurs when body does not produce enough insulin (the 
cause is unknown) 
2. Type 2 diabetes (T2D) - starts with insulin resistance and can progress to a lack 
of insulin (primary causes are lack of physical activity and obesity) 
3. Gestational diabetes – occurs in pregnant women with no history of diabetes 
According to the Public Health Agency of Canada (PHAC), 5 to 10% of diabetes patients 
have T1D and the remainder have T2D. Four percent of all pregnant women are affected 
by gestational diabetes which puts both the baby and mother at risk [2].  The cause for 
T1D and gestational diabetes has not yet been discovered by scientists. However, the list 
of risk factors for T2D are known to include [3]:  
· Being overweight or obese  
· Prediabetes (a condition that may occur before developing T2D) 
· Advanced age  
· Physical inactivity  
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· Having high blood pressure and/or high cholesterol  
· Having a family history of diabetes  
· Belonging to certain high-risk ethnic populations (e.g. Aboriginal, African, Hispanic, 
Asian) 
· Having a history of gestational diabetes   
· Having other conditions which may include vascular disease, polycystic ovary 
syndrome, and schizophrenia  
In prediabetes, the blood sugar levels are higher than normal but lower than the threshold 
which defines T2D. Prediabetes and T2D can be prevented by maintaining a healthy 
lifestyle, eating a balanced diet, and ensuring regular physical activity [4]. Undiagnosed 
T2D in Canadian adults was found to be 1.13% contributing to 20% of total T2D patients 
[5]. Diabetes also leads to other comorbidities and puts a great burden on patients as well 
as the healthcare system. This disease can impact the entire human body from head to 
toe, causing blindness, stroke, heart attack, kidney failure and even non-traumatic 
amputations (Figure 1). Early detection of prediabetes can help prevent diabetes, and 
early diagnosis of T2D can help physicians recommend guidelines to ensure a healthy 
post-diabetes lifestyle to lessen the chances of developing related comorbidities. 
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Figure 1 Impact of Diabetes on Human Body [2] 
Diabetes is a disease that needs to be monitored constantly. Even the slightest changes 
in the health of diabetic patients can have adverse effects on their wellbeing and in some 
cases even lead to death. Diabetes is often considered a modern society disease which 
can lead to other complications listed earlier. The Canadian Community Health Survey 
(CCHS) has been collecting information related to health status, healthcare utilization and 
health determinants for the Canadian population (Figure 2). It produces an annual micro 
data file which can be used to extract information related to diabetes as well as other 





Figure 2 CCHS 2017 Diabetes Chart [2] 
According to Diabetes Canada, 29% of Canadians are affected by diabetes. One million 
Canadians have diabetes but are yet to be diagnosed, and 3.9 million Canadians have 
been diagnosed with diabetes.  Statistics for prediabetes are also a great concern with 
an alarming number of 5.7 million Canadians. Cumulatively, out of 37 million, more than 
10 million people have diabetes or prediabetes (Figure 3). This number is expected to 
reach 33% by 2025 [7]. 
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Figure 3 Canadian Diabetes Association Infographic [7] 
  
While lack of physical activity, overweight and obesity makes one more vulnerable to 
diabetes, an additional observation was that clinically depressed people have 40%-60% 
increased risk of being diagnosed with T2D. The Diabetes Canada Backgrounder 
published in February 2020 has observed that 45.4% adults and 44.5% youth are 
physically inactive, 23.7% youth are either overweight or obese and 26.8% adults are 
living with obesity. The estimated mortality rate for Canadians with diabetes was twice in 
comparison with those without diabetes. Diabetes also has a significant cost impact with 
majority of patients in Canada paying more than 3% of their income for the treatments 
(Table 1). This cost is estimated to grow to $4.9 billion in 2030 [8]. 
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Table 1 Estimated prevalence and cost of Diabetes [8] 
1.1 Knowledge Discovery in Databases (KDD) and Diabetes 
 
Healthcare is one of the fields where foreseeing future outcomes and possibilities can be 
utilized effectively. Diabetes is one such disease, where early detection and management 
is vital to address the related health concerns. Foreseeing the possibility of a patient 
having diabetes and related comorbidities would be highly beneficial and this can be 
accomplished using predictive modeling which analyzes patterns and correlations in 
historical data. The entire process, methods, theories and techniques involved to make 
sense of available data is called Knowledge Discovery in Databases (KDD). Figure 4 
illustrates the basic steps involved in KDD [9].  
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Figure 4 KDD Steps [9] 
 
Data mining is a vital step of the knowledge discovery process and involves cleansing, 
integrating, mining, selecting, modeling, pattern recognition and knowledge 
representation of massive amounts of data (Figure 5). This process discovers unknown 
patterns that provide useful results and plays a valuable role in healthcare research to 
improve quality of life of patients diagnosed with health conditions [10]. Data mining can 
also be interfaced with statistics, machine learning, neural networks and inductive logic 
programming to play an important and decisive role in diabetes research [11]. Machine 
Learning is the process in which machines learn and adapt from experience by repeating 
a task for n number of times which in turn improves the performance. It is imperative to 
note that machine learning and data mining are two terms that are closely related with the 
latter being more generic. Thus, in literature, machine learning methods are also 
sometimes referred to as data-mining methods [9]. 
In healthcare, interfacing data mining with data warehousing and using Online Analytical 
Processing (OLAP) can enable efficient decision making. Data warehouses contain 
consolidated data which facilitates complex analyses and visualization through OLAP 
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[12]. OLAP has the capability to perform various operations such as rollup, drill-down, 
slice and dice, and pivot on the data warehouse. Rollup and drilldown increases and 
decreases the level of aggregation, respectively; slice and dice is used to select specific 
dimensions, and pivot re-orients the multidimensional view of the data warehouse.  
Machine learning and data mining can be utilized to extract knowledge from huge 
volumes of diabetes–related data. Data mining algorithms are used to identify correlations 
between different variables in the data source and build predictive models. These models 
have insightful information of diabetic patients, comorbidities and other demographics for 
the purposes of clinical administration, diagnosis as well as management of diabetes. 
 
Figure 5 Data Mining Process [11] 
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1.2  Data Visualization 
Interpreting data can be a complicated and tedious task. Complex statistics and equations 
may not be understood by all, but when visualized it can be made more relevant to the 
end user. Interactive data visualizations can help users to quickly identify patterns and 
trends which can enable effective decisions. An effective way to represent data is through 
dashboards which can translate key performance of organizations into visual displays.  
Dashboards allow visualization of huge amounts of data in an intuitive manner using 
charts, graphs, gauges and more. Interactive dashboards with color-coded visualizations 
are more appealing to the end user and enhances their experience. 
In healthcare, time is vital. Professionals have to make decisions rapidly to ensure optimal 
care for the well-being of patients and manage resources efficiently. Research shows that 
dashboards significantly reduce time when compared with the conventional approach of 
using electronic health records (EHR) for analysis and management [13]. For instance, a 
study compared the time for ten physicians to access ten common variables for two 
diabetic patients with similar volumes of clinical data using conventional EHR and a 
diabetes dashboard [13]. The mean time taken to access the ten variables for two diabetic 
patients was 1.9 minutes using the dashboard and 6.3 minutes with the conventional 
approach, showing that dashboards can significantly help reduce time spent by 
physicians and help optimize patient management. The research further established that 
usability analysis tools like dashboards can be an insightful asset for health care 
information technology [13]. 
In 2017, an electronic diabetes dashboard, iScreen, designed by the Canadian Diabetes 
Association was introduced [14]. For this research, T1D patients between 14-18 years 
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were assessed for other comorbidities. Fifty charts were used for review, 25 using iScreen 
and 25 without iScreen. The results showed an increase in appropriate initial screening 
and decrease in under- as well as over-screening of patients for nephropathy and 
retinopathy after using iScreen electronic diabetes dashboard (Figure 6). This study 
concluded that dashboards have potential to impact clinical outcomes and healthcare 
costs. 




In sum, an interactive diabetes dashboard listing the risk factors and comorbidities 
alongside different demographics has a potential to save time as well as enable effective 
decision making to optimize clinical outcomes and costs of treatment.  
 
1.3 Current State & Motivation 
 
Diabetes is one of the major chronic diseases worldwide and efforts are being made on 
a global scale to deal with it in the most efficient manner. Since early detection of diabetes 
is one of the major factors to prevent it, there has been considerable research done on 
developing diabetes risk calculators. For instance, in 2009, a simple tool [15] for detecting 
undiagnosed diabetes and prediabetes was proposed and data was used from the Third 
National Health and Nutrition Examination Survey [NHANES]. The models were built 
using two methods – classification tree analysis and logistic regression. In 2011, the 
Public Health Agency of Canada (PHAC) developed a non-laboratory based screening 
questionnaire to identify diabetes and prediabetes among middle-aged adults. The 
questionnaire was built on the basis of Finnish Diabetes Risk Score (FINDRISC) which 
led to the development of The Canadian Diabetes Risk Questionnaire (CANRISK) [15] 
which is a diabetes screening tool for Canadians aged over 40. There has also been 
significant research done on using data mining algorithms in this area [16] [17]. In 2013, 
three data mining models, namely, artificial neural networks (ANN), C5.0 decision tree 
and logistic regression were compared to predict diabetes and prediabetes [16]. The C5.0 
decision tree model demonstrated the highest accuracy for the dataset used in this 
research; this dataset was based on information collected from a questionnaire [16]. 
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Machine learning algorithms for detecting undiagnosed diabetic patients have also been 
compared and used to create best models using ANN and logistic regression [9]. A more 
comprehensive literature review is provided in Chapter 2. 
                                                                                                                        
Existing studies have focused more on building diabetes calculators (FINDRISC, 
CANRISK) but there is a lack of research when it comes to tools developed for identifying 
diabetes comorbidities [15] [18] [19]. Another limitation prevalent in existing work [16] [17] 
is that the risk factors identified for predictive modeling in diabetes uses survey data and 
interviews. While such databases can be useful to get an overall picture of the disease, 
the authenticity of the underlying data is highly questionable. Specifically, self-reported 
data has a high possibility of containing unreliable information [20]. Predictive modeling 
uses historical data as its base to build models and if this data is inaccurate, the model’s 
accuracy becomes questionable. One way to eliminate this issue is to use clinical data 
recorded by healthcare professionals. Clinical data is authentic as patient diagnosis has 
been confirmed by qualified physicians. However, obtaining clinical data for research can 
be quite challenging as it is seldom available in the public domain due to privacy concerns. 
Considering these factors, this research proposes building predictive models for 
diagnosed diabetic patients using a clinical dataset obtained from Northern Health. These 
models will enable users to identify hidden patterns in historical data and predict the 
likelihood of comorbidities resulting in effective diabetes management. The models have 
been integrated with an interactive diabetes dashboard for visual analytics. 
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1.4 Problem Statement 
 
Predictive models that accurately forecast the likelihood of various diabetes comorbidities 
could be an efficient tool for healthcare providers as well as patients. This could facilitate 
early diagnosis and interventions with the possibility to prevent other comorbidities as well 
as effective management of diabetic patients reducing the cost quotient on the healthcare 
system. The results from these predictive models should be user friendly and beneficial 
for end users; this leads to the first research question. 
1.4.1 How to enhance diabetes management using intuitive visualization 
techniques?
Chronic conditions such as diabetes require frequent follow-ups and monitoring of 
patients for effective management. This can be a tedious task considering the large 
number of patients to track, and the required tests for related comorbidities. Summarized 
information of individual patients can enable healthcare professionals to take useful and 
timely decisions. Aggregated data visualization of multiple patient records can give an 
overview of the entire dataset while drill-downs can let users navigate to finer granularities 
focusing on individual patients. This can be accomplished with an interactive diabetes 
dashboard which identifies patients with their associated clinical visits and treatment 
plans.  
A previous study described earlier has shown that conventional approach using EHR took 
6.3 minutes to identify all the associated variables for diabetic patients compared to 1.9 
14
minutes using a diabetes dashboard. The mean number of mouse clicks were 60 for EHR 
and significantly reduced to 3 using the dashboard [13]. 
Taking these factors into account, an interactive diabetes dashboard is built with the 
following features: 
· Color coded visualization of existing and predicted data in the form of charts and 
graphs with available demographics (i.e. patient Local Health Area (LHA), patient 
community, age and comorbidities) 
· Results of models represented in comparative charts  
· Aggregated data with drill down capability to view information at finer granularity 
This interactive diabetes dashboard will help decision makers to identify patterns and 
understand the relationship of different variables specific to comorbidities and patients 
which is complicated and time consuming using EHRs. These relationships also help 
identify associated risk factors using historical and predicted data. This leads to the next 
research question: 
1.4.2   What are the vital risk factors for diabetes comorbidities? 
Diabetes is associated with a number of comorbidities affecting the entire human body. 
Analyzing and applying data mining algorithms to existing clinical patient data can help 
identify the risk factors specific to comorbidities.  This research focuses on three common 
comorbidities which are acknowledged by Diabetes Canada - hypertension, congestive 
heart failure and renal failure [3]. The risk factors associated with each of these 
comorbidities and the prominent common risk factors are presented using a diabetes 
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dashboard. Another interesting observation would be to associate the comorbidities 
themselves with the help of a predictive model; this leads to the final research question: 
1.4.3 What is the likelihood of a patient to be diagnosed with other 
comorbidities? 
Diabetes Canada has observed that diabetic patients lifespan can reduce by five to 15 
years; further, diabetes has been attributed as the reason for death of one in every ten 
Canadian adults in 2008-2009 [8]. These patients are also more likely to be hospitalized 
with cardiovascular disease and twelve times more susceptible to end-stage renal 
disease compared to the general population. These observations emphasize the 
importance of being able to predict the likelihood of comorbidities so that early detection 
and efficient diabetes management can be achieved. Taking these factors into account, 
predictive models to find the likelihood of diabetic patients with the following three 
comorbidities are proposed: 
· Hypertension  
· Congestive Heart Failure 
· Acute Renal Failure 
The results from these models can act as a useful guideline to identify patients vulnerable 
to specific comorbidities and recommend appropriate management to prevent escalation 
to further comorbidities. Effective diabetes management would ensure optimal patient 
care as well as reduced costs on the healthcare system. 
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1.4.4  Methodology 
This research focuses on building predictive models using existing diabetes related 
clinical data. The model predicts the probability of diabetic patients to develop related 
comorbidities. To make the results of the model easily accessible, a simple user-friendly 
assessment tool is developed which predicts the probability of the three comorbidities to 
the users.  In addition, an interactive dashboard is designed to visualize insightful 
information representing several years of diabetes data including the identified risk factors 
related to various comorbidities.  
The raw clinical data is integrated into a database using SQL Server Management Studio 
(SSMS) 15.0 [21]. The integrated database is used to build the predictive models with 
IBM SPSS modeler 18.2 [22] which predicts the likelihood of the three comorbidities 
(congestive heart failure, hypertension and renal failure). The models help to identify the 
prominent risk factors for these comorbidities as well as the significance of variables for 
the predictions.  The results produced by each model and the identified risk factors are 
analyzed in detail. 
An interactive diabetes dashboard is built using SQL Server Reporting Services 15.0 
(SSRS) which is a component of Microsoft Business Intelligence tool stack [23]. SSRS is 
an effective reporting platform which includes various data visualization tools such as 
charts, graphs, and gauges to represent data; capability to integrate maps and embed 
images is also included. The aggregated results are presented in a visually pleasing 
format with the option of drilling down to reports at finer granularities. 
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Finally, a user friendly tool is developed using IBM SPSS modeler. This tool allows 
diabetic patients and healthcare professionals to view results generated by the models 
predicting likelihood of one of the three comorbidities. 
The study methodology is described in detail in Chapter 3. 
1.5  Contributions 
This research has two major contributions. Firstly, predictive models for Canadian 
diabetic patients which forecasts the likelihood of related comorbidities have been 
developed. These models could be used by healthcare professionals as a guideline to 
identify patients who are at higher risk of developing predicted comorbidities and ensure 
effective management of diabetes. Clinical data of diabetic patients who accessed 
Northern Health (NH) facilities between April 1 2012 and March 31 2018 has been used 
to train and test the models for accuracy. 
The second contribution is the design and development of an interactive diabetes 
dashboard. Data visualization in the form of charts and graphs can enable healthcare 
professionals to have a better and deeper understanding of the variables associated with 
the disease. The dashboard provides individual as well as aggregated data at facility and 
community levels with drill down and drill through reporting. This information can be useful 
to identify the gaps in healthcare and enhance related services by making informed 
decisions in a timely manner. These contributions are described in detail below: 
Identifying diabetic-patient comorbidities:  Predictive models built specific to diabetic 
patients predicting the likelihood of comorbidities - benign hypertension, congestive heart 
18
failure and acute renal failure. These results can be used as a guideline by healthcare 
professionals to identify and treat patients who are at a higher risk for developing these 
comorbidities. 
Enhanced patient-care:  Early detection of patients who are at high risk for developing 
one or more comorbidities could help prevent further complications to their health and 
timely treatment ensuring overall well-being of patients. 
Reduce healthcare costs: Identified high risk patients who receive timely care are less 
susceptible to other complications; this in turn benefits the patients as well as the 
healthcare system with elimination of complex treatments reducing the burden of cost. 
Holistic healthcare approach: Interactive diabetes dashboard provides an overview of 
the current state of diabetes and diabetic patients in the selected dataset. The embedded 
drill downs allow filtering of results by various demographics such as Health Service 
Delivery Area (HSDA), LHA and comorbidities. The historical information is presented in 
a way which facilitates analysis and assists decision makers in identifying gaps in 
provision of healthcare. The stakeholders can use this information to develop plans for 
improving related services. 
Diabetes comorbidity prediction tool: The results from the model are incorporated into 
a user-friendly web form which predicts the possibility of one of the three comorbidities 
for diabetic patients. The interactive web form asks for a user to enter input for the 
selected variables and predicts the value of the target variable using the underlying 
models.  This tool could be used by the healthcare professionals to enhance treatment 





Chapter 2  
Related Work  
   
Diabetes being a worldwide chronic illness has no shortage of research especially with 
focus on early diagnosis and detection of the disease. One reason for such extensive 
research in this direction is the cost and toll of diabetes management on healthcare 
systems. The research community has explored various data mining techniques to detect 
and diagnose diabetes. The research has encompassed not only diabetes, but all 
associated comorbidities including hypertension, renal failure and cardiovascular 
diseases. Diabetes research thus branches into various fields including but not limited to 
healthcare, data mining and data visualization. The literature review presented in current 
chapter was done to align with the focus of this research, that is, building predictive 
models for diabetes comorbidities and designing an interactive diabetes dashboard. 
 
This chapter is divided in three main sections. Firstly, representative studies on diabetes 
and data mining are presented. These include analysis of various data mining algorithms 
and techniques used in the study of diabetes and related comorbidities. A review of the 
application of research work to develop user-friendly tools such as diabetes calculators 
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is then presented. Finally, the use of data visualization for enhanced and cost effective 
healthcare is explored. Limitations of existing literature are provided to identify research 
gaps that are addressed by the work presented in this thesis. 
   
2.1 Diabetes and Data mining  
 
Data mining plays a huge role in the healthcare sector with algorithms that have the ability 
to analyze, detect and predict the presence of diseases in patients. Early detection of 
diseases can help in timely and efficient decision making by healthcare professionals. 
Diabetes is one such disease where data mining can be a vital part of developing tools 
that can facilitate enhanced healthcare service. In this section, research with respect to 
data mining and diabetes is explored and techniques for implementing predictive 
modeling specific to diabetes are analyzed. 
   
In 2012, a study was done to predict T2D using data mining. The aim of the research was 
to apply artificial metaplasticity on multilayer perceptron (AMMLP) as a data mining (DM) 
technique for diabetes and compare results with the decision tree, Bayesian classifier and 
other algorithms [24] .The comparisons were done using classification accuracy, analysis 
of sensitivity and specificity and confusion matrix. The results showed an accuracy of 
89.5% for AMMLP which was superior to decision tree and Bayesian classifier algorithms. 
The dataset used for this research was obtained from the National Institute of Diabetes 
and Digestive and Kidney Diseases. This dataset comprised of a specific group of Pima 
Indian women tested for diabetes. The sample used eight variables:  
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· number of times pregnant 
· plasma glucose concentration 
· glucose tolerance test 
· diastolic blood pressure 
· triceps skin fold thickness 
· serum insulin 
· body mass index  
· diabetes onset within five years 
This research [24] had a sample size of 768 which was further reduced to 763 after 
elimination of records with missing data. It is also to be noted that out of 768 patients only 
268 had diabetes. T2D is common among both men and women but this dataset did not 
include men and it was also focused on a specific group making the relevancy of results 
for other groups questionable. It was concluded that AMMLP performed with better 
accuracy but it was compared only with two other classifier algorithms. 
 
In 2013, a research project proposed automated detection of diabetes mellitus using 
neural networks without patients undergoing clinical tests [17].  The neural network had 
a total of 27 nodes (13 input, 13 hidden and 1 output) [17]. The input nodes are the 
variables with shared historical data, the hidden nodes are where the computation occurs 
and the output node is the result for the given input.  The neural network was built using 
the backpropagation1 algorithm and out of 20 datasets tested, 18 produced accurate 
1 “backward propagation of errors” calculating gradient of error function
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results with an overall accuracy of 92.8%. For this research, a survey was done using 
100 datasets. Each data set included people of various ages, genders and lifestyles to 
get an unbiased result. Eighty datasets were used for training and twenty were used for 





· Weight loss 
· Thirst increase 
· Hunger increase 




· Bladder, skin infections 
 
Considering that the data was collected using surveys and was self-reported, the 
authenticity of the diagnostics becomes questionable. This research [17] also mentions 
another study using ANN and feature extraction which achieved an accuracy of 94.6% 
for classifying patients as diabetic and non-diabetic.  
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Another study [16] was conducted to compare three data mining models (ANN, decision 
tree and logistic regression) to predict diabetes or prediabetes by various risk factors [16]. 
A questionnaire to obtain information on demographics, family diabetes history, 
anthropometric measurements and lifestyle risk factors was given to 1,457 participants, 
735 of whom had diabetes. The following twelve input variables were used: 
· Age 
· Family history of diabetes 
· Marital status 
· Education level 
· Work stress 
· Duration of sleep 
· Physical activity 
· Preference for salty food 
· Gender 
· Eating fish 
· Drinking coffee 
· Body mass index 
The output variable was a flag variable with possible values of 0 and 1, where 1 indicated 
if the person had diabetes or prediabetes. Results from the three predictive models are 




Table 2 Comparison of Data Mining Models 
       Logistic regression          ANN   Decision tree  
 Sensitivity  79.40% 79.40% 78.11 
 Specificity  73.54% 65.47% 75.78% 
 Accuracy  76.54% 72.59% 76.97% 
 
In conclusion, the decision tree had the highest classification accuracy, followed by 
logistic regression and ANN. Classification accuracy is the percentage of correct 
predictions in a model and is considered to be a vital performance indicator. A limitation 
of this study [16] was that the sample population chosen was only from two communities 
in Guangzhou, China and cannot be considered an appropriate representation of the 
entire population. Also, some of the individuals who participated in the study provided 
self-reported data which make the results less reliable.  
 
In a recent study published in 2020, data was collected from over 230,000 participants 
during the years 2006-2017 to develop a T2D risk prediction model using machine 
learning algorithms [25]. This research excluded all diabetic participants as well as any 
participants taking medication for diabetes. The collected medical, behavioral, 
demographic and incidence data was used to predict T2D in participants at 3, 5, 7 and 10 
years. The participants selected in the research were followed up for the entire time period 
thus making it a longitudinal dataset.  Three machine learning algorithms, random forest, 
multilayer feedforward artificial neural network implementing a deep-learning approach, 
and a gradient boosting machine approach, were compared with conventional logistic 
regression model. The AUC (Area under Curve) in machine learning models was higher 
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than the conventional regression model. AUC is a statistical performance measurement 
which is used to validate the model. A higher AUC implies better prediction capabilities of 
the model. The highest accuracy was recorded by gradient boosting algorithm with an 
AUC of 79% in 3-year prediction and 75% in 10-year prediction. The machine learning 
models also predicted BMI as the vital risk factor contributing to T2D. It was also noted 
that diabetes incidence was recorded higher among men than women over the ten-year 
period. Limitations of this research were that it used self-reported data and the exclusion 
of participants was done by use of diabetes related medication instead of a clinical 
diagnosis. 
 
The studies presented above focused on predicting diabetes [16] [17] [25]. The next few 
research works [24] [26] explore the use of data mining techniques to improve 
management and treatment plans for diagnosed diabetic patients. Management of 
diabetes is a critical challenge for healthcare professionals as well as for the patients 
themselves. Diabetic patients have higher risk of being diagnosed with multiple 
comorbidities which, in turn, increases the complexity of treatment and care. Hence, it 
would be ideal to predict comorbidities using data mining techniques. Existing literature 
shows a few studies that have focused on this topic. 
 
A comorbidity study [24] done on diabetic patients identified that hypertension plays a 
critical role in its association with other comorbidities. Hypertension was identified as a 
critical factor for T2D patients having stroke as well as dyslipidemia [27]. For this research, 
20,314 patients with T2D were chosen from Keimyung University Dongsan Medical 
Center. Apriori algorithm was used to find the association between T2D and various 
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comorbidities. Hypertension had the highest association followed by gastritis and senile 
cataract. Apriori algorithm was implemented through a proprietary tool, Dx Analyze, 
which aided in the process of data cleansing and construction of data marts as well. A 
limitation of the study was that the data represented only one medical facility and the Dx 
Analyze tool needs to be applied on data from multiple facilities to check for relevancy of 
the results. The authors also acknowledge the limitations of Apriori to determine causality 
of disease and recommend further research considering chronology of diseases 
in patients.  
 
In another interesting research, mortality of diabetic patients in ICU was predicted 
[26]. The MIMIC-III database which records ICU admissions was used for this study. 
There were a total of 10,318 diabetic patients in this database; this number came down 
to 4,111 after exclusion of missing values for blood glucose. Existing algorithms to predict 
mortality were used for the models - Charlson Comorbidity Index (CCI), Elixhauser 
Comorbidity Index and Diabetes Complications Severity Index (DCSI). CCI and 
Elixhauser calculate risk-scores based on ICD-9 diagnosis codes for each patient while 
the DCSI is an alternative risk score designed specific to diabetic patients. The results 
showed AUC values to be 0.694, 0.682 and 0.656 for DCSI, Elixhauser and CCI, 
respectively. The AUC improved to 0.785 when all three metrics were combined using 
logistic regression. In addition, the random forest model achieved an accuracy of 0.787. 






· Admission Type 
A limitation of this research was that it used random sampling of 70/30 for analysis which 
resulted in an imbalance of less than 10% of positive cases. Also, it did not consider 
patients directly admitted for diabetes related care because it was complicated to identify 
with the different diagnostic codes recorded for a patient. Length of stay is a variable 
which was not analyzed and is recommended to be explored by the authors. This 
research also recommends exploring other machine learning algorithms such as random 
forest and ANN for better predictions.  
 
Data mining algorithms can be effectively used and adopted in healthcare to build 
predictive models with patient-specific information to predict diseases such as diabetes. 
Predictive models for T2D comorbidities could contribute to associating the relation 
between risk factors and identify onset of specific comorbidities [28]. The models can also 
be used to develop tools to aid in informed decision making for optimized treatment of 
diabetic patients. User-friendly electronic tools to identify patients with diabetes can be 
highly beneficial for efficient treatment and management of diabetes. The next section 







2.2 Diabetes Calculator  
 Early identification of diabetes is ideal for well-being and treatment of patients and 
diabetes calculators are an effective tool to accomplish this. These calculators can act as 
a guideline for patients to analyze their risk of being diagnosed with diabetes; higher the 
potential risk, more advisable and essential to contact a physician.  Over the years, there 
has been a lot of research done globally on diabetes calculators, some of which is 
presented in this section.   
   
In 2003, a tool to predict T2D (Diabetes Risk Score) was developed to identify individuals 
at risk without undergoing laboratory tests [18]. The risk factors taken into account were:   
· Age   
· Body Mass Index (BMI)  
· Waist circumference  
· History of antihypertensive drug treatment and high blood glucose  
· Physical activity  
· Daily consumption of fruits, berries, or vegetables   
For this study [18], a random population sample between ages 35-64 was selected and 
followed for 10 years. Each category was assigned a score using multivariate logistic 
regression model coefficients. The cumulative sum of all scores was calculated as the 
Diabetes Risk Score (DRS). The research identified 182 cases of diabetes incidence in 
4,435 subjects. DRS has been implemented in Finland as one of the tools in their diabetes 
prevention program. The SAS (version 8.2; SAS Institute, Cary, NC) software was used 
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for analysis. This research has several limitations. First, the risk factors do not include 
family history of diabetes which is an important factor contributing to an increased risk of 
acquiring the disease [29]. The researchers recommend addition of this factor in future 
work.  The individuals with high glucose levels were not excluded at the baseline under 
the assumption that no biochemical tests were performed at that stage. In addition, the 
data used to build the model was obtained from surveys and the national population 
register. 
 
In 2005, Indian Diabetes Risk Score (IDRS) was proposed for screening undiagnosed 
diabetic patients [19].  Indian Diabetes Risk Score used four risk factors: age, abdominal 
obesity, family history of diabetes and physical activity. Multiple logistic regression 
analysis was applied using undiagnosed diabetes as the dependent variable. When risk 
score was greater than or equal to 60, the IDRS had an accuracy of 61.3% with a positive 
predictive value of 17.0% and a negative predictive value of 95.1%.  Receiver Operating 
Characteristic (ROC) curves showed that area under ROC curve was 0.698 with a 
confidence interval of 95%. Indian Diabetes Risk Score, which categorizes risk factors 
based on their severity, can be a cost effective tool for mass screening in developing 
countries like India where a large number of cases are undiagnosed. The risk score for 
this research was derived from Chennai Urban Rural Epidemiology Study (CURES). The 
response rate for this study was 90.4% and the results were subject to internal 
validation.  The sample size for this research was 2,350 patients. This research [19] did 
not take dietary consumption into account which is one of the recommended risk factors 
by the American Diabetes Association. In addition, anti-hypertensive medication was 
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excluded as one of the variables considering that a lot of people do not take medication. 
The other shortcoming of this research is that it is a cross-sectional study and the authors 
recommend validating this study with prospective studies. A cross-sectional study collects 
data from various sects of the population at a given time opposed to collecting data over 
time. For medical research involving predictions, prospective studies are preferred as 
they are longitudinal and the results obtained can have a better relevance.   
 
A simple tool for detecting undiagnosed diabetes and prediabetes was proposed using 
data from the Third National Health and Nutrition Examination Survey [NHANES] [30]. 
The models were built using two methods – classification tree analysis and logistic 
regression. The diabetic risk calculator tool used the following risk factors:  
· Age  
· Waist circumference  
· Gestational diabetes  
· Height  
· Race/Ethnicity  
· Hypertension  
· Family History   
· Exercise  
 
The classification tree model was used based on its ease of use and the results obtained 
are shown in Table 3:  
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Table 3 Diabetes Risk Calculator Results for the United States [30] 
 
 ROC area under the curve for undiagnosed diabetes was 0.85 and for prediabetes was 
0.75. ROC is used to evaluate the performance of models where the true positive rate is 
represented by sensitivity and false positive is represented by specificity. With ROC 
analysis, optimal models for predictions can be evaluated. This research [30] eliminated 
the variables for body mass index (BMI) in favour of height and weight, and the cholesterol 
variables were eliminated due to missing fields and low predictor value. Another important 
variable eliminated was diabetes in any blood relative. There were 18 variables chosen 
but not all of them were used in the final model. Finally, the tool is yet to be developed 
into a patient friendly electronic version for broader use.   
 
In 2011, the Public Health Agency of Canada (PHAC) came up with a strategy for 
preventive intervention [15]. Before such an intervention can be applied in Canada, it is 
important to have an early detection strategy to be successfully implemented. The PHAC 
developed a non-laboratory-based screening questionnaire to identify diabetes and 
prediabetes among middle-aged adults. The questionnaire was built on the basis of 
Finnish Diabetes Risk Score (FINDRISC) which led to the development of The Canadian 
Diabetes Risk Questionnaire (CANRISK) [15]. 
 
   Undiagnosed Diabetes Prediabetes 
Sensitivity  88% 75% 
Specificity  75% 65% 
Positive Predictive value  14% 49% 
Negative Predictive value  99.3% 85% 
 ROC 85% 75% 
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CANRISK asks 13 questions that categorizes people as low risk, moderate risk and high 
risk. The low risk has a score of less than 21, and the high risk has a maximum score of 
86. The moderate risk scores can vary from 21 to 32. The 13 questions focus on the 
various risk factors such as age, gender, height & weight (to calculate BMI), blood 
pressure and blood pressure during pregnancy (gestational diabetes). CANRISK also has 
questions related to family history of diabetes as well as ethnicity and education. Each of 
these variables contribute to the total diabetes risk score. In case of moderate risk, 
CANRISK recommends consulting a healthcare practitioner whereas in the case of high 
risk blood sugar test is recommended. CANRISK has been implemented and translated 
into different languages [15]. Limitations of this work are that some ethnic groups are 
under-represented in the sample and CANRISK is yet to be evaluated as a screening tool 
for high risk patients. 
 
2.3 Data Visualization and Diabetes  
   
Healthcare is one of the areas where abundant data is stored in various disparate formats. 
Integrating and organizing such data is an ongoing challenge faced by healthcare 
providers. Critical data can be challenging to be retrieved from electronic health records. 
Data visualization can help solve this challenge and lead to enhanced patient care and 
optimized diabetes management. Research has shown that management of diabetes 




In a study, patients were assessed by a diabetologist and given access to a web portal 
which had information regarding diabetes, their personal health status as well as the 
ability to contact the diabetologist [31] . The primary goal of this research was to monitor 
the blood glucose levels (A1C) and to observe differences between users who had access 
to the web portal and those who did not. This study observed that the web portal users 
had lower levels of A1C compared to the non-users. Further, it confirmed the usefulness 
of a web based tool to enhance patient management and cut costs in the long term. This 
research used only 8% of the original patients (157/1957) for the final analysis as only 
157 patients had covariate data and did a follow-up visit. This study also did not explore 
the demographic factors that would influence the usage of the web portal, and did not 
distinguish between patients with T1D and T2D.  
 
There has been work done towards building dashboard for diabetes. As mentioned in 
Chapter 1, the iScreen electronic diabetes dashboard [14] observed that evaluation of 
decision support tools facilitate complicated screening for diabetes care. However, 
iScreen included only T1D patients and had a small sample size of only fifty patients.  
 
Mosaic is a project funded by the European Union (EU), specifically to explore predictive 
models and decision support system for T2D care and management; a clinical decision 
support system (CDSS) dashboard was built for this project [32]. The dashboard explored 
diabetic patient data and risk of complications; it consisted of three sections consolidating 
metabolic control, frequent temporal patterns and drug purchase patterns. An outcome 
assessment and research support system (ORSS) was designed for clinicians 
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[32]. Figure 7 shows an example of CDSS where patients are grouped by complication 
categories and details. 
Figure 7 CDSS Diabetic Patients Complications 
 
Upon evaluating the CDSS for nine clinicians, it was observed that T2D patients who had 
access to CDSS recorded shorter durations with their clinical visits and screening for 
complications increased in the visits indicating optimized patient care. The researchers 
observed that the dashboard can be improved by implementing a more detailed human-
computer interaction study. The dashboard was evaluated for patient management but 
not for any clinical outcomes. There were a limited number of clinicians involved and they 
all were from the same facility. 
Nevertheless, chronic diseases such as diabetes can be aided with the help of data 
visualization tools such as dashboards to support clinical decision-making, including 
diagnosis, treatment plans, and effective management if used in a coordinated fashion to 




2.4 Summary  
Research in data mining and diabetes has identified risk factors which have a strong 
relationship to diabetes, such as age, BMI and dietary consumption. Predictive models 
play an important role in forecasting future health outcome of patients. Unfortunately, 
majority of existing research work in prediction focuses on comparing different data 
mining algorithms to determine the most efficient algorithm to build the model. 
Undoubtedly, there is a lack of research to identify risk factors leading to comorbidities 
such as cardiovascular disease, renal failure, and hypertension for diagnosed diabetic 
patients. Several tools have been developed for early diagnosis and management of the 
disease. One of the major issues with the current risk calculators is that the majority of 
them are paper-based questionnaires as opposed to online tools [33]. The identified 
research gaps discovered in current literature are summarized below: 
Self-reported data: Majority of the published work is based on survey data and 
questionnaires which makes the data quality highly questionable. This, in turn, impacts 
the reliability of the predictive models which are built on top of this data.   
Low Count of Diabetic Patients: Many datasets had a low count of diabetic patients, 
and there is a lack of research using datasets which exclusively represent diagnosed 
diabetic patients. 
Domain-Specific Datasets: The datasets used in majority of the researches were 
specific to an ethnic group or to a particular facility which makes results applicable and 
relevant only to the group associated with the dataset. 
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Location Demographics: The datasets used lack information on demographics such as 
the community and facilities accessed by the patients. Location demographics can 
contain useful information specific to a community or facility which can represent insightful 
information. Also, there is limited research for predictive models based on data for 
diabetes patients in Canada. 
Adding New Input Variables: 
Majority of the studies have included age, gender, ethnicity and BMI as input variables 
for building the models. Variables such as length of stay, discharge date, and availability 
of family physician have not been explored to evaluate their impact on the models. 
 
Diabetes Comorbidity Assessment Tool: 
Several calculators for diagnosing diabetes have been developed over the years, 
including CANRISK, but tools available for identifying comorbidity or multi-morbidities in 
diabetic patients are scarce. 
 
To overcome these limitations, predictive models for diabetes comorbidities have been 
built using NH clinical data. Clinical data eliminates the issue of self-reporting as only 
diagnosed patients are part of the dataset. This dataset has exclusive information of 
diabetic patients who are diagnosed with either T1D or T2D, also this dataset is specific 
to Canada and has information of all patients who have accessed NH facilities from 2012 
to 2018. This includes patients from different communities accessing various facilities 
which makes it a generic dataset rather than specific to a domain. The models included 
the lesser explored variables such as length of stay, access to family physicians and 
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facilities. The importance of each of these variables with respect to the different 
comorbidities was analyzed for building the predictive models. The results of the diabetes 
comorbidity models were integrated with a user-friendly tool to predict the risk of 
hypertension, cardiovascular disease and renal failure in diabetic patients. In addition to 
this, a dashboard has been developed for visualization of existing clinical diabetes data 
to give the users insightful and useful information about diabetes. This enables users to 
interact and analyze anonymized patient data for effective decision making and improved 
healthcare outcomes. The existing research has served as a guideline to choose relevant 












Chapter 3  
Methodology 
This research has three interrelated components. First, a model for predicting diabetes 
comorbidities is proposed. Second, an interactive dashboard has been developed to 
provide insights about diabetes using visual analytics. In the process, hidden data 
patterns are uncovered and the newly discovered knowledge is imparted via this 
interface. Finally, a user-friendly assessment tool allows users to benefit from the model 
results for their specific cases. These components are explained in detail in this chapter. 
 
  
3.1 Proposed Model 
The key components of the model are shown in Figure 8.This model was studied for three 
representative comorbidities using several data mining algorithms and the NH clinical 
dataset of diagnosed diabetic patients. IBM SPSS modeler was used to identify and apply 
the most efficient data-mining algorithms for prediction of these comorbidities. 
Relationships between different comorbidities and demographics were also identified. 
The visual analytics dashboard was built using SSRS as the underlying platform. The 
front end for the assessment tool consists of a simple web form wherein the user enters 
information such as age, diagnosis code and health service delivery area. This 
information is processed based on a Microsoft SQL server database back end and the 
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predictive models to determine the possibility of diabetes comorbidities in future. To 
recap, after importing the Excel csv data file into the SQL Server database, the entire 
process can be grouped into three distinct phases, namely, predictive modeling, 
dashboard design and assessment tool. The steps within each phase are listed below. 
 
 
Figure 8 Components for Predictive Modeling and Data Visualization  
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Phase 1: Data preprocessing and modeling 
· Data was cleansed and prepared for the model. 
· After data preprocessing, testing and training tables for three diabetes 
comorbidities were created. 
· Relationships were established within the database to associate demographic and 
diagnostic data from different tables for data visualization. 
· Three predictor variables were chosen from the top twenty diagnostic codes. A 
separate model was built for each of these variables. The remainder diagnostic 
codes together with demographic data then became the input variables. 
· Various data mining algorithms such as logistic regression, decision tree and 
artificial neural network together with their ensembles were compared for 
relevance and accuracy. 
· To evaluate the model, the data was divided in two sets, one for training and the 
other for testing. A larger dataset was used for training which improved accuracy 
of the algorithm. The test data, which was a smaller dataset, was then used to 
evaluate performance. 
Phase 2: Dashboard 
· A dashboard was designed to allow users to analyze/compare various key 
performance indicators (KPIs) and filter results by the selected parameters. The 
drilldown capabilities of the dashboard allow filtering by specific demographics and 
understand KPIs at a finer granularity. 
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· The performance of various data mining algorithms is also shown in the 
dashboard. 
Phase 3: Diabetes Comorbidity Assessment tool 
The results from predictive models were integrated with a web-based, user-friendly 
assessment tool to predict likelihood of comorbidities for individual patients. This tool 
displays the risk score for diabetes comorbidities. 
3.2 Data Source 
A clinical dataset obtained from Northern Health (NH) has been used for this research. 
This dataset consists of patients who have accessed one of the eighteen NH facilities in 
three Health Service Delivery Areas (Northeast, Northern Interior, Northwest). The NH 
dataset exclusively consists of diagnosed diabetic patients who were admitted to these 
facilities for either acute care or day surgery. All patients were diagnosed with at least 
one of 4,592 unique diagnostic codes.  The dataset used for this research consists of a 
total of 141,900 records representing 34,824 unique admissions for the period from April 
1, 2012 to March 31, 2018. It is to be noted that these timelines were specified in fiscal 
years (2012/13-2017/18) and there were no cases of gestational diabetes. The variables 
included in this dataset are: 
Ø Patient Code 
Ø Stay Code (this code is unique to a particular acute/daycare stay (visit)) 
Ø Diagnosis Code Order of Entry (identifies the order in which the diagnosis codes 
were abstracted) 
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Ø Health Service Delivery Area 
Ø Facility Name 
Ø Diagnosis Code (ICD-10-CA code that describes the diagnoses, conditions, 
problems, or circumstances of the patient during the length of stay in the health 
care facility) 
Ø Diagnosis Code Long Description 
Ø Age Units 
Ø Average Total Length of Stay (the summation of both the acute care length of stay 
and the ALC length of stay) 
Ø Physician Code (has family doctor or not) 
This dataset is a reliable source for building predictive models and analyzing data 
because it only consists of diagnosed diabetic patients with associated diagnostic 
codes. 
In addition, it is also to be noted that this dataset has been anonymized by Northern 
Health to protect the privacy of patients. No personal information of patients was 
included in the dataset.  
 
3.3 Data Preprocessing 
Data preprocessing is the technique of cleaning and processing the data to ensure 
efficient and accurate adaptation by different data mining algorithms. The performance of 
predictive models not only depends on the data mining/machine learning techniques, but 
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is also highly dependent on the data quality. Hence, it is imperative to ensure that negative 
factors such as noise, missing values and inconsistencies are addressed through data 
preprocessing methods [34]. Figure 9 shows the common data preparation and data 
reduction techniques involved in data preprocessing [35].  
 
Figure 9 Tasks in Data Preprocessing [35] 
 
For this research, data preprocessing has been done to obtain a specific set of relevant 
variables through extensive analysis and filtering.  
Dataset Preprocessing: The dataset provided by NH was an Excel sheet in a csv format. 
This sheet was converted into a database. There were a total of 141,900 records with 
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stay codes repeating multiple times. To resolve this, pivot queries were used to get a 
table with the 34,824 unique admissions. This was verified with the original Excel sheet. 
This pivoting required that diagnosis codes for comorbidities be added as columns in the 
table for each unique admission. This was deemed to be an unnecessary overhead 
because 73% of these codes occurred in less than ten cases in the original dataset. The 
process implemented for exclusion of comorbidities is explained in detail in the next 
section. Considering all these factors, the top twenty diagnosis codes with maximum 
counts were chosen to build the model. These codes together with their descriptions and 
counts are listed in Table 4 below: 
Table 4 Top Twenty Diagnostic Codes by Count 
 Diagnosis Code Diagnosis Description Count 
1 E119 




Type 2 diabetes mellitus with certain circulatory 
complications 
6,516 
3 I100 Benign hypertension 3,598 
4 E149 




Type 2 diabetes mellitus with poor control, so 
described 
2,452 
6 I500 Congestive heart failure 2,303 
7 E1123 
Type 2 diabetes mellitus with established or 
advanced kidney disease 
2,262 
8 N179 Acute renal failure, unspecified 1,714 
9 N390 Urinary tract infection, site not specified 1,673 
10 N0839 Unspecified glomerular disorders in diabetes mellitus 1,429 
11 E1138 
Type 2 diabetes mellitus with other specified 
ophthalmic complication not elsewhere classified 
1,337 
12 H251 Senile nuclear cataract 1,297 
13 E1128 
Type 2 diabetes mellitus with other specified kidney 
complication not elsewhere classified 
1,293 
14 Z22300 Carrier of drug-resistant staphylococcus 1,255 
15 J189 Pneumonia, unspecified 1,102 
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Based on literature and Table 4, three diagnosis codes were selected as predictor or 
target variables: 
1. I500 (Congestive Heart Failure) 
2. I100 (Benign Hypertension) 
3. N179 (Acute Renal Failure) 
For each of these diagnosis codes, training and testing datasets were initially created with 
a ratio of 70:30. This ratio was later adjusted to study the efficiency of the models. 
It is to be noted that the final dataset used to build the predictive models aggregated 
patient admissions which resulted in each patient to have only one record to be consistent 
with the total number of unique patients (14,016) after exclusions. This is due to the 
reason that some patients had recorded a comorbidity in one of their admissions but in 
the subsequent admissions, these comorbidities were missing which lead to data 
inconsistencies. To handle this particular issue, it was assumed that if a patient had been 
diagnosed with one of the twenty comorbidities in any one of their admissions, then they 
were recorded with that particular comorbidity. This particular issue has also been 
explained in the challenges section of this chapter. 
16 E109 
Type 1 diabetes mellitus without (mention of) 
complication 
1,058 
17 Z22302 Carrier of drug-resistant enterococcus 996 
18 U980 Place of occurrence, home 967 
19 Z515 Palliative care 958 
20 E1178 




3.4 Inclusion and exclusion  
For relevance of data, inclusion/exclusion was done at two stages. First, NH ensured that 
the data consisted of only diabetic patients. Second, irrelevant /redundant data was 
excluded and only relevant variables based on literature were retained. 
NH Inclusion/Exclusions: Discharges were included if at least one of the following 
diagnosis codes was found on the record: E11*, E12* E13*, E14* and/or E232.  
· Type 1 Diabetes codes begin with E10 
· Type 2 Diabetes codes begin with E11 
· Type other codes begin with E13 and include Diabetes Insipidus E232 Diabetes  
· Type unspecified codes begin with E14 
3.5 Predictive Modeling Inclusions/Exclusions:  
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Large datasets face curse of the dimensionality problem which impedes operations of 
data mining algorithms raising the computational costs [36]. One solution to handle this 
issue is to use the Feature Selection (FS) algorithm. FS eliminates irrelevant and 
redundant variables. The NH dataset includes demographic and diagnostic data for each 
patient with every admission. The variables including the twenty diagnostic codes 
identified in data preprocessing stage were evaluated for importance using the FS 
algorithm [37]. 
 
Figure 10 Feature Selection Model 
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Figure 11 FS Model Results 
 
Figure 10 shows the FS model used on the NH clinical dataset. In this Figure, the SQL 
data source represents the NH database, and Type identifies the data types of variables; 
Type is also used to select the target predictor variable I500 (Congestive Heart Failure).  
The golden model nugget contains the results of the FS model. Figure 11 shows the 
variables evaluated and ranked by order of importance by the FS model. The Field column 
provides the names of input variables which were described earlier in the data 
preprocessing section. The Measurement column describes the variable type as identified 
by the SPSS modeler either as continuous, nominal, ordinal or flag. Continuous is used 
for integers, real numbers and date/time; Nominal can be used for numeric/string/date or 
time; Flag is used for two distinct values such as true/false or binary values 0 or 1.  It is 
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to be noted that out of the twenty diagnosis codes included, only seven were identified as 
important by FS. This is due to the reason that remainder of the diagnosis codes had a 
majority of values which were ‘0’ which prevented FS from ranking them; instead, these 
codes were categorized as “Single category too large”. Since these variables were not 
evaluated as unimportant by FS, they were included in the final dataset as input. The 
finalized list of variables including diagnostic and demographic information was explored 
further for data analysis and visualization. The data mining algorithms which were used 
include Logistic Regression, CHAID, Neural Network, Random Forest, Bayesian Network 
and Ensemble. Some of these algorithms are described later in this chapter. 
The following variables were also excluded: 
· Stay Code - This code is unique to a particular acute/daycare stay (visit) 
· Fiscal Year - A fiscal year ranges from April 1 of the current year to March 31 of 
the following year 
· Fiscal Period - Periods within the fiscal year (The days in period 1 and 13 will 
vary, the remaining periods 2-12 will always be 28 days) 
· Discharge Date - The date the patient was discharged from the hospital 
· Institution Type - Identifies whether the hospital stay was an acute care stay or a 
daycare visit 
· Age Code - Age code is either Year (Y), Months (M), or Days (D) 
· Acute Length of Stay - The length of stay in days associated with the acute care 
portion of the stay 
· ALC Length of Stay - ALC length of stay is the number of days a patient is 
classified as alternate level of care 
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· Patient Community - Community of patient residence 
· Patient LHA - Local Health Area of patient residence 
· Patient Province - Province of patient residence 
 
Stay code, Fiscal Year, Fiscal Period, Discharge Date were excluded because patient 
data from different admissions was aggregated into one record for each patient. Age 
Code specified the units in which the age was recorded (year, months or days). This only 
resulted in removal of five patients.  ‘Acute Length of Stay’ and ‘ALC Length of Stay’ were 
excluded as the variable Total Length of Stay captured this information by default. Since 
multiple admissions for patients and their diagnoses were aggregated, the average of 
Total Length of Stay was calculated for all patients. Patient Community and LHA were 
excluded due to patient migration across communities resulting in data inconsistency.  
Patient Province was also excluded as majority of patients were from British Columbia 
and this information was redundant. These eleven exclusions reduced the dataset to 
twenty-six variables. Out of these variables, Patient Code (unique identifier) and the target 
variable are not considered to be input variables thereby leaving twenty-four variables 
which are listed below: 
1. E119 - T2D without complications 
2. E1152 - T2D with certain circulatory complications 
3. E149 - Unspecified diabetes mellitus without (mention of) complication 
4. E1164 - T2D with poor control  
5. I100 - Benign hypertension 
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6. E1123 - T2D with established or advanced kidney disease 
7. N179 - Acute Renal Failure 
8. N390 - Urinary tract infection 
9. N0839 - Unspecified glomerular disorders in diabetes mellitus 
10. E1138 - T2D with other specified ophthalmic complication 
11. H251 - Senile nuclear cataract 
12. E1128 - T2D with other specified kidney complication 
13. Z22300 - Carrier of drug-resistant staphylococcus 
14. J189 - Pneumonia, Unspecified 
15. E109 - T1D without complication 
16. Z22302 - Carrier of drug-resistant enterococcus 
17. U980 - Place of occurrence, home 
18. Z515 - Palliative care 
19. E1178 - T2D with multiple other complications 
20. Facility HSDA - Facility Health Service Delivery Area 
21. Facility Name - Specifies facility in which patient is admitted 
22. Age - Specifies age of patient in years 
23. Average Length of Stay - Average of total length of stay  
24. Physician Code - Specifies if a patient has family physician or not 
It is to be noted that, the above input variables are for predicting I500 which is the reason 
for it not to be included as an input. An analogous process was followed for predicting 
I100 and N179.  
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Out of 14,021 patients, there were only five patients who had their age units recorded 
either as month or days; these were excluded from the study thus reducing the dataset 
to 14,016 records. 
 
 
3.6 Predictive Modeling 
Predictive modeling is a statistical data mining technique normally used to predict future 
behaviour. Predictive models analyze historical and current data to predict future 
outcomes. Data mining algorithms, such as logistic regression, decision tree and neural 
networks, have been used for building predictive models for early detection of diabetes 
[11]. There are two types of learning used by data mining algorithms - supervised learning 
and unsupervised learning [43]. Supervised learning uses labeled data whereas 
unsupervised learning uses unlabeled data. Labeled data refers to data accompanied 
with metadata, while unlabeled data lacks this information. Unsupervised learning has 
been primarily used to solve association, clustering and anomaly detection problems. In 
contrast, supervised learning are more suited to solve classification problems. With the 
exclusive use of labeled data, this research makes use of supervised learning methods 
in order to generate predictive models for classification. Some of the data mining 
algorithms which use classification are briefly explained below: 
Artificial Neural Networks 
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Artificial Neural Networks (ANNs) are biologically inspired models which have recently 
found their applications in the field of healthcare. ANNs are based on the brain structure 
and can be used to model extremely complex nonlinear functions. ANNs can be used in 
sophisticated predictive applications such as multilayer perceptron (MLP) and radial basis 
function (RBF) networks [38]. 
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Figure 12 Neural Network Mapping 
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As seen in Chapter 2, ANNs have been effectively used for building predictive models for 
diabetes. An example of neural network mapping  shows how input data is matched to 
the predictor variable which in this case was I100 (Hypertension) (Figure 12). Each 
neuron output is calculated by the sum of inputs and activation functions.  
Some advantages of ANNs are given below [39]: 
· Information is stored on a network which ensures that it can function even with 
missing values; models can be trained to produce results even with incomplete 
data. 
· ANNs lend well to parallel processing. 
· ANNs provide better fault tolerance; if one or more cells is corrupted, it still 
generates results. 
A notable disadvantage of ANNs is that solutions probed are unexplained in some cases 
which reduces trust on the network. 
 Logistic Regression 
Logistic regression has been used typically in the analysis of binary outcomes. It is a 
statistical method for prediction of probability of occurrence of an event which is 
represented by 1 and a non-event by 0. Predictor variable in logistic regression can be 
either qualitative or quantitative [38]. 
Figure 13 shows the importance of the different input variables identified by the logistic 
regression model for predicting I100 (Hypertension). 
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Figure 13 Logistic Regression Predictor Importance 
Decision Tree  
A decision tree assigns probability to each of the possible choices based on the context 
of the decision and acts as a decision-making device. Decision tree has attribute nodes 
that can be linked to two or more subtrees. Brieman’s classification and regression tree 
(CART) is one of the popular decision tree algorithms [16]. 
Random Forest 
Random Forest is an algorithm where subsets of a given dataset are chosen and multiple 
classification trees are generated. A forest is then created from the ensemble of these 
trees. Random Forest has been used in diabetes research and is recommended as an 




Bayesian Network  
Bayesian Network algorithm is based on probabilistic theory and represents a set of 
variables and their dependencies in the form of an acyclic graph [41].  This could be used 
to identify relationships between a disease and its associated symptoms. Bayesian 
Network has been used in the past to predict T2D patients [42]. 
CHAID 
CHAID (Chi Square Automatic Interaction Detection) is a decision tree technique [43]. 
CHAID can be used to find the relationship between input and target variables. It is to be 
noted that CHAID can have limitations due to the sample size of predictor variable. CHAID 
has also been used to build predictive models for diabetic patients [44]. 
The performance of a predictive model depends on various factors such as data quality, 
structure of data and variable selection [36]. In 2013, a study was done comparing the 
performance of logistic regression and artificial neural network (ANN) models for 
identifying risk factors for  diabetes mellitus using IBM SPSS Modeler [38]. Figure 14 
shows the overall data modeling process, and Figure 15 shows the process specifically 
for partitioned data. The dataset consisted of 229 diabetes patients, 69.9% of whom had 
uncontrolled blood glucose level. Results revealed that ANN model had a higher 
classification accuracy of 72.5% in comparison to logistic regression which had an 
accuracy of 69.9%. Similar results were recorded for partitioned data with ANN model 
having an accuracy of 72.5% while logistic regression had an accuracy of 71.35%. 
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Figure 14 Data Mining Process for Entire Sample Data [38] 
Figure 15 Data Mining Process for Partitioned Sample Data [38] 
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3.7  IBM SPSS Modeler 
A number of predictive modeling tools such as R, Weka, Orange, Rapid Miner, GraphLab 
Create, Octave and IBM SPSS are available. The IBM SPSS Modeler is a graphical data 
science and predictive analytics platform which assists in providing insights to improve 
decision making. For this research, IBM SPSS Modeler v18.1 [22] was chosen due to its 
features listed below: 
· Advanced statistical analysis 
· Easy to use and flexible 
· Supports multiple data sources including Microsoft SQL database 
·  Graduate licensing packages for students. 
· Supports all phases of data mining including model development, deployment and 
refreshing 
· Ability to merge data from multiple sources 
· Options to choose advanced data mining algorithms to build predictive models 
· FS algorithm which helps identify important variables 
· Supports use of smaller datasets 
· Scalable platform makes it accessible to users of different skill levels 
· Automated data preparation and modeling 
· Visual analytics 






The major challenge was the selection of appropriate variables as there was a lot of 
diagnostic data with minimal records. Data inconsistency was another issue as there were 
patients who had missing diagnosis codes on readmission. Both these challenges are 
elaborated in detail below. Each patient had been recorded with at least one or more 
diagnosis codes for every admission. The Table 5 below shows the distribution of 
diagnosis for patients. 
 
Table 5 Diagnosis/Patient Distribution 







To filter and select the diagnosis codes which were relevant to this research was a tedious 
task. This has been elaborated in the data preprocessing section. Even after filtering and 
selecting prominent twenty diagnostic codes, there were inconsistencies found with the 
data. For instance, there were patients who had been recorded with T2D the first time 
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they came in and on readmission, the same patient was recorded with Type 1 diabetes. 
An example of this case scenario is shown for a patient in Figure 16. 
Figure 16  Data Inconsistency Example 
 
The data inconsistency issue raises the question that what happened to the patient’s 
previous diagnosis of T2D on the first admission.  
Another challenge was that not all of the recorded diagnosis codes were repeating on 
readmission. For instance, diagnosis code I100 (hypertension) was recorded for a patient 
on the initial admission but this diagnosis code was not recorded upon readmission 
(Figure 17). This data inconsistency made it extremely challenging to build the predictive 
models with longitudinal data. To resolve this issue, the dataset used for building the 
predictive models retained all diagnosis codes for a patient if it was recorded in any of 
their admissions.  
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Figure 17 Data Inconsistency I100 (hypertension) 
To illustrate this, the diagnosis code I100 (hypertension) was retained for the patient even 
though it was not recorded in the recurring admissions (Figure 17). For patient 110 (Figure 
16)  diagnosis codes for both T1D and T2D were retained. This ensured that no diagnosis 
code was missed for building the predictive models. The corresponding dashboard is 
consistent with this logic as well. 
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As mentioned earlier, all patients in this dataset were diabetic with diagnosis codes 
recorded for T1D, T2D, other types of diabetes, diabetes insipidus and unspecified 
diabetes. In total, there were 100 diagnosis codes for different types of diabetes with zero 
or more associated comorbidities. These 100 diagnosis codes included diabetes 
comorbidities such as E1123 (Type 2 diabetes mellitus with established or advanced 
kidney disease) and E1128 (Type 2 diabetes mellitus with other specified kidney 
complication not elsewhere classified).  For kidney/renal comorbidities, there were a total 
of 84 diagnosis codes. The word ‘kidney’ was found in 45 diagnosis codes and 39 
diagnosis codes contained the word ‘renal’. Some of the patients who  were recorded with 
diagnosis codes such as E1123 were also recorded with other diagnosis codes such as 
N179 (Acute renal failure) (Figure 18). The American Urological Association quotes renal 
as a synonym for kidney [45], this was an interesting observation which could lead to the 
possibility of combining diagnosis codes with the word renal/kidney under one umbrella. 
However, there were 84 diagnosis codes for words kidney/renal alone and they included 
different types of diabetes as well as other comorbidities. To combine these meaningfully, 
a considerable medical background would be required. Thus, it was not explored further 
in this research.  All of these challenges made it tedious to finalize the predictor variables 
filtering the different diagnosis codes. Thus diagnosis codes with more prominence were 
chosen as the target variables. 
In Figure 18, it can also be seen that a patient was recorded with T2D on their first visit, 
but the same patient was recorded with unspecified diabetes in a subsequent admission. 
Considering these anomalies in the dataset, the predictive models were built for all 





Figure 18 Diabetic Patient with Kidney Disease 
 
Please note that the stay code is unique for each patient visit and no patient information 
is included in Figure 16, Figure 17 and Figure 18 to ensure patient privacy. 
 
Integration 
Software from different vendors such as Microsoft SQL [46] for database, Microsoft SSRS 
[47] for dashboard and IBM SPSS Modeler [22] for building predictive models required 
integration packages to be built. For instance, to connect the Microsoft SQL data source  
[46] with IBM modeler [22], an ODBC (Open Database Connectivity) data source had to 
be created. Similarly, the results from SPSS modeler had to be exported to MS SQL 
database for analysis using SSRS [47]. 
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Dashboards are an effective tool which allow visualization of large amounts of data in an 
intuitive manner. The key performance indicators are integrated into visual displays which 
can be further drilled down for finer granularity.  These do not only provide insight into 
data, but can be effective for quickly finding information. For instance, it was 
demonstrated that the mean time to find all data elements was 6.3 minutes using 
conventional approach compared to 1.9 minutes using a diabetes dashboard. The 
research further established that analysis tools like dashboards can be an insightful asset 
for healthcare information technology [27]. As seen in Chapter 2, a similar research [28] 
by the Canadian Diabetes Association established that health professionals were more 
effective in treating diabetes patients when using a dashboard which provided knowledge 
of other risk factors and associated guidelines [28]. Similarly, the patients who are 
presented with a dashboard listing the risk factors tend to benefit from the knowledge 
contained therein.  
To build a dashboard, it is essential to choose an appropriate visualization tool. A number 
of tools are now available for this purpose. These include Tableau [48], QlikView [49], 
Datawrapper [50], Fusioncharts [51] and SSRS [47]. In this research, SSRS was selected 
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due to its simplicity, capability to produce interactive visualizations and ability to adjust 




SSRS is a business intelligence module which enables users to create visually appealing 
reports via charts, maps and dashboards [47]. SSRS provides features including:  
· Compatibility with different data sources ranging from simple Excel sheets to 
databases 
· Interactive sorting capabilities 
· Drilldown/Drillthrough reporting  
· Security via access controls 
· Intuitive Visualization 
· Export features – reports can be exported to various formats including Word, 
Excel, PowerPoint, pdf, TIFF, MHTML, CSV, and XML 
SSRS requires a backend database and a wrapper for rendering reports in a browser. 
For this research, the Microsoft SQL server database was used. 
SSRS reporting has been effectively used in healthcare to maximize profits, minimize 
risks, reduce costs and enhance patient experience. In addition, it has also been used for 
presenting data in a user-friendly form (Figure 19). 
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Figure 19 COVID Prevalence in the World [29] 
3.11 Summary 
The proposed models are based on several data mining algorithms and produce data-
driven results which can assist physicians in developing effective treatment plans. The 
dashboard presents insightful information such as obesity rates based on geographical 
locations, food habits and the overall trend for diabetes over the years. Such information 
can educate the users about diabetes and its impact on health.  The assessment tool, 
which uses results from predictive models, would facilitate users to be better informed 
about diabetes comorbidities. The existing diabetes risk score calculators are mostly 
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based on limited paper based questionnaires and not easily accessible. In summary, the 
study methodology consists of the following steps: 
· NH dataset was imported into SQL database 
· Data preprocessing techniques were used to eliminate redundant information. 
· Data analysis allowed selection of the input and three predictor variables for 
diabetes comorbidities. 
· The database served as a data source for the IBM SPSS Modeler and was used 
to evaluate relative performance of various data mining algorithms. 
· The accuracy of each algorithm was determined using training and testing 
datasets. 
· The results from the models were displayed using SSRS via an interactive 
dashboard. 
· A user-friendly tool was developed to calculate the risk of developing comorbidities 
for individual patients. 
· The dashboard was integrated with the diabetes assessment tool. 
The information provided by the predictive model will be both helpful and insightful for 
diabetes patients as well as non-diabetic users to have a better understanding of their 





Chapter 4  
Experiments and Results 
 
In this chapter, the experiments and results of this research are discussed. This chapter 
is split into two parts. First, the diabetes dashboard is explained, and then results from 
the predictive modeling for three target variables are presented. For both these parts, the 
NH clinical dataset was used which included only diabetic patients who accessed one or 
more of the NH facilities between the period 2012-2018. 
The Diabetes Dashboard consists of three main reports with drilldown capabilities. The 
first report shows overall aggregated statistics for the NH diabetes dataset; the second 
report is the Diabetes Types and Comorbidities dashboard which shows the prominent 
comorbidities for patients with different types of diabetes and also includes the prominent 
Primary Diagnosis Codes. The third report is the HSDA comparison which shows 
aggregated patients and admission statistics across the three Health Service Delivery 
Areas -  Northwest, Northeast and Northern Interior.    
Predictive Modeling is done using five base classification algorithms together with their 
ensemble for three comorbidities (Hypertension, Congestive Heart Failure and Acute 
Renal Failure) using IBM SPSS Modeler. The results for each target variable is shown 
with the corresponding explanation and analysis. The relationships found between the 
input and target variables using the FS algorithm are also explained followed by a 
summary of the analysis. 
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4.1 Diabetes Dashboard 
Figure 20 Diabetes Dashboard 
Figure 20 shows the main diabetes dashboard which displays the clinical data sliced 
along various dimensions including population, diagnosis codes, diabetes types, 
admissions and comorbidities for patients admitted in NH facilities over the years. The 
dashboard also allows navigation to reports at a finer granularity via drilldowns. Each of 
the charts/tables included in this dashboard is further explained below. The image on the 
top-right was obtained from Diabetes Canada [8].  
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Figure 21 Diabetes Dashboard Overall Statistics 
Figure 21 shows an overview of aggregated statistics obtained from the NH clinical 
dataset. The top row shows that there were a total of 14,021 patients with 34,824 
admissions which averages out to approximately three admissions per patient. Out of 
these patients, 12% with T1D, 80% were diagnosed with T2D, and remaining 8% with 
other types of diabetes (includes diabetes insipidus, other and unspecified types). The 
Diagnosis/Patient Statistics table shows that the average age of all patients over the years 
was 63 and an average of 2,337 patients were admitted each year. Another observation 
was that the admitted patients recorded an average of four diagnoses from the possible 
4,592 diagnosis codes. The maximum number of diagnosis codes recorded for a patient 
was 89, there were four patients who recorded more than 80 comorbidities and fifty 
patients who recorded between 50-80 comorbidities. A detailed breakdown of 
comorbidities is shown in Figure 25.  The number of diabetic patients and admissions by 
province is also shown in Figure 21. Drilldown from this chart shows these numbers for 
each LHA specific to British Columbia (Figure 22). It should be noted that the higher 
number of patients in the drilldown is due to the patient migration which records the patient 
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more than once. However, this anomaly does not impact the model. LHAs with fewer than 
ten patients and those recorded as ‘Unknown‘ were grouped in a single category labeled 
as ‘Other’. 
 
Figure 22 Diabetes Dashboard - Patients/Admissions Drilldown 
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Figure 23 Diabetes Dashboard - Patients/Admissions by Year 
Figure 23 shows the number of patients and admissions for each year from 2012/13 to 
2017/18. The maximum number of patients were recorded for the year 2012/13 (3,763) 
and the minimum was in 2016/17 (1,672), also the patients were consistently decreasing 
till 2017/18 followed by a slight increase in 2017/18 (1,848).  This trend is consistent with 
Statistics Canada numbers. In 2012/13, 5.7% of British Columbia residents were 
diagnosed with diabetes which was lower than national average of 6.5%. In the following 
years (2013/14, 2014/15) this number dropped to 5.5% compared with the national 
average of 6.6% (2013/14) and 6.5% (2014/15). In 2017/18, the national average went 
up to 7.3% and British Columbia recorded a corresponding increase to 5.9%. On the other 
hand, the admissions trend is not consistent with the trend observed for number of 
patients. In 2015/16, the number of admissions (5,443) was lowest and 2017/18 recorded 
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highest number of admissions (6,483) even though the number of patients was almost 
identical. It should be noted that the admissions include patients from previous years and 
also readmissions of the same patient. For instance, the year 2017/18 recorded 6,483 
admissions for the cumulative number of patients (14,021) and not the new patients 
(1,848) only. 
Figure 24 Diabetes Dashboard – Patients by Diabetes Type (Yearly) 
Figure 24 shows the number of patients by diabetes types (T1D, T2D and Other).  The 
number of patients consistently decrease for T2D until 2016/17 (1,320) from 2012/13 
(3,021) and then increases slightly in 2017/18 (1,413). A similar pattern was observed for 
T1D patients. These observations are consistent with Figure 23 which showed  an 
increase of patients in 2017/18. For other types of diabetic patients, a different trend was 
observed which recorded the lowest number of patients in 2017/18 (130) and the highest 
number in 2013/14 (308).  Since this group represents only 8% of the total number of 
patients, the impact on the overall trend is relatively insignificant. 
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Figure 25 Patients with Comorbidities 
Figure 25 shows the comorbidities per patient. The average number of diagnosis for a 
patient was observed as four with the majority of patients (7,140) having two to five 
comorbidities.  There were fewer patients with higher number of comorbidities. The lowest 
number of patients (756) was recorded for 16-20 comorbidities and then an increase was 
observed for 20+ comorbidities. On further breakdown for patients with greater than 
twenty comorbidities, it was observed that 990 patients recorded 20-40 comorbidities, 
thirty-three patients recorded 50-70 comorbidities, seventeen patients had 60-80 
comorbidities and only four patients recorded over 80 comorbidities. As mentioned earlier, 
all patients in the NH dataset had at least one type of diabetes (T1D, T2D or other). The 




Figure 26 Diabetes Dashboard – Prominent LHAs with Diabetic Patients 
 
 
Figure 26 shows the prominent communities which had the highest number of diabetic 
patients. The dataset consisted of 305 communities and seventy LHAs of which Prince 
George recorded the maximum number of patients consistently over the years. The 
University Hospital of Northern British Columbia in Prince George accounted for 53% of 
the total patients and 47% of overall admissions. The GR Baker Memorial Hospital in 
Quesnel accounted for 7% of the total patients and 13% of the overall admissions. It was 
also observed that all communities showed an increase of patients in the year 2017/18 
from the previous year making it consistent with the trends noted earlier (Figure 23 and 
Figure 24).  Since Prince George and Quesnel are categorized as both LHA as well as 
communities, these names will refer to one or the other depending on the context. Peace 
River South and Peace River North consists of thirteen and sixteen communities, 
respectively. Quesnel has three communities and Prince George has fifteen communities 
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including itself.  It is also to be noted that the LHAs are specific to the patient and not to 
the facilities. For instance, a patient can have their community recorded as Quesnel and 
still be admitted to a facility in Prince George. The top ten LHAs with the maximum number 
of patients were Prince George, Peace River South, Quesnel, Peace River North, 
Terrace, Nechako, Prince Rupert, Kitimat, Smithers and Burns Lake. 
 
Figure 27 Diabetes Dashboard - Prevalence of Diabetes by LHAs 
Figure 27 shows prevalence of diabetes per thousand of the population.   The population 
figures were obtained from Census Canada (Peace River North and Peace River South 
- 2001; Prince George and Quesnel - 2016).   
Similar to  
Figure 26, Prince George recorded the maximum prevalence per thousand residents over 
the study period.  An interesting observation is that while Prince George and Quesnel did 
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not show any change between 2016/17 and 2017/18, both Peace River North and Peace 
River South showed a slight increase over the same period. This is consistent with  
Figure 26  where  a spike in the number of patients was observed for both Peace River 
North (32%) and Peace River (11%) South during this period.  
 
4.1.1 Diabetes Types and Comorbidities  
 
79
Figure 28 Diabetes Types/Comorbidities Dashboard 
Figure 28 shows the overall aggregated statistics broken down by diagnosis codes 
specific to the types of diabetes  and comorbidities.  Using charts and tables, the clinical 
data from NH has been sliced along various patient groups (T1D, T2D and other types of 
diabetes) and diagnosis. Each of these charts is explained below along with the 
drilldowns, where applicable. The image on the bottom right has been taken from 
Diabetes Canada [8].  
Figure 29 Diabetes Types/Comorbidities Dashboard Statistics 
 
 
Figure 29 shows vital statistics related to comorbidities.  Out of 14,021 patients, it was 
observed that one in five had hypertension and one in ten had heart/renal failure. These 
three comorbidities accounted for 39% of the total patients and 22% of the total 
admissions. This observation also became the basis of selection of the three target 
variables identified in chapter 3. 
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Figure 30 Diabetes Types/Comorbidities Dashboard - Diagnosis Codes/ Diabetes Types 
The diagnosis codes table in Figure 30 are grouped by different types of diabetes and 
other comorbidities. It was observed that comorbidities accounted for 98% of the total 
diagnosis codes.  
Figure 30 also shows the number of patients with different types of diabetes. ‘Other’ type 
of diabetes includes diabetes insipidus and unspecified diabetes types. It is observed that 
80% of the total patients had T2D and the remaining 20% had T1D or Other types of 




Figure 31 Diabetes Types/Comorbidities Dashboard - Diagnosis Codes/ Diabetes Types 
Upon admission, multiple diagnosis codes are normally entered, one of which becomes 
the primary ‘most responsible’ code. Figure 31 shows the top five primary diagnosis codes 
which account for 23% of total patients and 15% of total admissions. In this figure, while 
H251 is showing the maximum number of patients’ primary diagnosis, it is not the case 
when all diagnosis types are included.  For example, H251 accounted only for 4% of the 
total admissions and 7% of the total patients. Thus, it was not identified as a target 
variable when building the model. It is observed that when H251 and I500 were included 
in the diagnosis set for the patient, they were recorded as primary diagnosis in 98% and 
48% of the cases, respectively. The description for the diagnosis codes is shown in the 
table in Figure 31. 
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Figure 32 Diabetes Comorbidities Dashboard- T2D Comorbidities 
 
Figure 32 shows the top five comorbidities for patients with T2D together with their 
corresponding description. It was observed that 65% of the patients with T2D were 
diagnosed with one or more of these comorbidities, 48% were diagnosed with one or 
more of the top three comorbidities (I100, I500, N179). These three comorbidities were 
selected as target variables for the predictive model. 
83
Figure 33 Diabetes Comorbidities Dashboard- T1D/Other Diabetes Comorbidities 
Figure 33 shows the top five comorbidities diagnosed for patients with T1D or any other 
types of diabetes excluding T2D.  These comorbidities represented 95% of the total 
patients in this group.  The three target variables (I100, I500, N179) selected for building 
the models accounted for 63% of patients. The top two comorbidities (hypertension and 
congestive heart failure) are the same in both sets (Figure 32 and Figure 33). However, 
the third and fourth comorbidities (N390 and N179) are reversed in the two sets. N179 
was selected as the target variable because of its high cumulative impact. Figure 34 
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shows the top five diagnosis codes embedded with different types of diabetes. Four of 
these codes (starting with ‘E11’) represent T2D patients which can be attributed to the 
fact that majority of the patients in this dataset have been diagnosed with T2D. 
 
Figure 34 Comorbidities Dashboard- Diabetes Specific Diagnosis Codes 
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Figure 35 Diabetes Types/Comorbidities Dashboard- Diabetes Diagnosis Codes Drilldown 
 
Cumulatively, the total number of patients represented by these codes exceed 14,021 
patients because the same patient can be diagnosed with multiple codes. This issue was 
not obvious in earlier charts because the patients were either filtered by diabetes types 
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or by primary admissions. Figure 35 shows the drilldown report  which lists the top twenty 
diabetes specific diagnosis for all patients. 
4.1.2 HSDA Comparison 
 
 
Figure 36 Diabetes HSDA Dashboard 
Figure 36 shows a comparison of aggregated statistics for each of the three HSDAs –
Northwest (NW), Northern Interior (NI), Northeast (NE) - which recorded 24%, 57%, and 
19% of the total patients, respectively.  An interesting observation was that 6% of the 
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patients migrated to other communities and were thus counted more than once. This, 
however, does not impact the number of visits because those are recorded independent 
of the patient’s community. On average, approximately two admissions per patient were 
recorded across all HSDAs, including patients from outside of BC.  Even though NI 
recorded majority of the patients as well as admissions, the average length of stay (LOS) 
was very similar across all HSDAs. A similar pattern was also observed for patients who 
had family physicians. In BC, there were a total of nineteen communities which recorded 
over 100 patients for the years 2012/13 to 2017/18. Among these, Fort Nelson had 85% 
of patients without a family doctor followed by Fort St. James, Houston, Queen Charlotte 
and Burns Lake (73%, 42%, 40%, 33%). The five communities with the highest number 
of patients (Prince George, Quesnel, Fort St. John, Terrace and Dawson Creek) had 14%, 
27%, 18%,14% and 11% patients with no family doctors, respectively. NE had the highest 
number of patients visiting from outside of BC. The facilities visited most by these patients 
were Dawson Creek District Hospital (69 patients), Fort St. John General Hospital (37 
patients) and University Hospital of Northern British Columbia (28 patients). All of these 
patients were from Alberta. 
The number of patients who were only recorded with only one diagnosis code was less 
than 2% in each of the HSDAs. Patients with two to five comorbidities represented 53%, 
50% and 59% of the total number of patients in NW, NI and NE, respectively. Patients 
with six or more comorbidities were 45%, 49% and 39% for the same HSDAs, 
respectively.  
While 85% of total patients had a diagnosis code related to T2D, the three HSDAs had a 
variation ranging from 72% (NE) to 90% (NI); NW was closer to the overall average (82%). 
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Of the eighteen facilities across all HSDAs, UHNBC admitted 50% of the total patients 
followed by Mills Memorial (11%) Hospital and Fort St. John General Hospital (10%). The 
lowest number of patients was admitted by McBride & District Hospital (0.5%).  
Figure 37 shows the annual breakdown of cumulative visits and number of patients across 
all HSDAs. This drilldown is obtained by clicking on one of the HSDA maps in Figure 36. 










An interactive diabetes dashboard was developed using dataset consisting of diabetic 
patients who had accessed Northern Health facilities from the years 2012 to 2018. The 
dashboard consisted of three main reports: 1) the diabetes dashboard which contained 
overall aggregated statistic of this dataset, 2) the diabetes types and comorbidities 
dashboard where the data was grouped by different types of diabetes and comorbidities 
of the patients, and 3) the HSDA dashboard which grouped the data by three HSDAs – 
NE, NW and NI.  
The following are a few observations which were made from these reports: 
· 80% patients were diagnosed with T2D  
· Average age of patients was found to be sixty-three  
· Average Number of diagnosis per patient was four  
· Number of new patients were consistently decreasing till 2016/17 with a slight 
increase in 2017/18 
· HSDA Northern Interior recorded 57% of the total number of patients where LHA 
Prince George had maximum number of Patients and Admissions.  
· All three target variables (I100, I500, N179) were recorded as one of the top five 
comorbidities for T2D patients (excluding the diabetes diagnosis codes) 
This dashboard also had drilldown capabilities to view reports at finer granularity by 
various parameters such as HSDA, LHA and patient comorbidities. 
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4.2 Predictive Modeling 
Predictive modeling is the process of applying data mining algorithms on historical data 
to predict the likelihood of future outcomes. For the three target variables (I100, I500, 
N179), predictive models were built using six data mining algorithms. The corresponding 
results are explained in this section.  
The six data mining algorithms chosen for building the predictive models were: 
1. Bayesian Network 
2. Neural Network 
3. Random Forest 




4.2.1 Training Models 
 
For each of the three target variables, the dataset was split such that the training 
component contained 70% of the patients diagnosed with the corresponding target 
variable. The remaining 30% was then used for testing. This resulted in a patient 
distribution as shown in Table 6. For instance, N179 had a total of 1,303 patients who 
were split into training (913) and testing (390) datasets, respectively. This number (1,303) 
represents 9.3% of the total number of patients. In order to maintain this 70:30 ratio, the 
desired number of patients in the dataset was then determined which in this case was 
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8,274 (59% of the total patient population). The remainder was used for testing. This 
method was consistently applied to all target variables. A higher percentage of records in 
the training dataset allowed the models to learn the underlying patterns better, which 
helped in making better predictions. 
Table 6 Training/Testing Datasets 
Figure 38 shows the training model for prediction of I100 (hypertension) using five data 
mining algorithms with different nodes. Each of these nodes is explained below: 
Target Variable Training Testing Total Patients
I100 66% 34% 18.9% (2,656)
I500 65% 35% 9.9% (1,385)
N179 59% 41% 9.3% (1,303)
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SQL Access: This is the data source node which establishes a connection to diabetes 
database and extracts the dataset consisting of the finalized twenty-six variables for 
building the predictive models. Twenty-four of these variables were the input variables 
and the remaining two variables were excluded because they were either a unique 
identifier (Patient Code) or the target variable (I100). 
Type: The Type node is used to specify the data type of the selected variables as either 
nominal, categorical, continuous, flag or ordinal. This node allows to specify whether a 
variable is input or target. Additionally, it also gives an option to specify one variable as 
the unique identifier (Patient Code). 
The twenty diagnosis codes and Physician Code were all assigned as a flag including the 
target variable. The flag datatype is used for variables which have binary values, such as 
0 or 1. Patient Code, Age, Average Length of Stay were assigned as continuous which is 
used to describe numeric values including decimals. Facility Health Service Delivery Area 
and Facility Name were assigned as nominal which is used for storing string values. For 
this predictive model, I100 was set as the target variable and the remaining variables 
were the input.  Figure 39 shows the twenty-six variables with this information, where the 
Measurement column shows the data type, the Values column shows the sample values, 
the Missing column shows missing values in the dataset, the Check column specifies if a 
variable needs to be excluded, and the Role column specifies the variable as input, target 
or unique identifier. 
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Data Mining Model Node: The Type node is connected to the data mining model nodes 
each of which represent one of the five (Bayes Network, Neural Network, Random Forest, 
Logistic Regression, CHAID) algorithms. The Ensemble algorithm is not shown as it is 
explained later in this chapter.   Executing these nodes generates the model nugget which 
contains the results of the trained model for the selected algorithm.  
                                 
Figure 39 Predictive Modeling Training - Type Node 
Analysis Node: The results from the model nugget are connected to the analysis node 
which analyzes the prediction accuracy of the model. An example of analysis node for 
predicting I100 using neural network is shown in Figure 40 where approximately 81% of 


















Figure 41 Predictive Modeling Testing 
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Figure 41 shows the testing model used for predicting one of the target variables (I100). 
The nodes shown are explained below: 
SQL Access: The data sources represent the testing dataset with 30% of patients with 
I100. A major difference between the testing and training data source is that the former 
does not contain information of the corresponding target variable. 
Type: The data type node used in testing is identical to the one used in training with the 
exception of target variable. It is necessary for the training and testing to have identical 
input variables with the specified data types for successful execution. An example of the 
type node used for testing is shown in Figure 42 where there is no target variable (I100) 
information being sent to the trained model nugget. 
Trained Model Nuggets: These nuggets possess the required information to predict the 
target variable. Executing these trained models generate the results of one of the five 
corresponding data mining algorithms (Bayesian Network, Neural Network, Random 
Forest, Logistic Regression, CHAID). These results include the predicted values of the 
target variable (I100) which is pushed to an output table. 
Output Table: This table contains the results of the executed training model nugget along 
with the other input variables. The predicted values of the five algorithms were evaluated 
for accuracy and are explained in the data analysis section.  
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Figure 43 Predictive Modeling Ensemble Training/Testing 
 
Figure 43 shows the training and testing models for the Ensemble algorithm. The SQL 
access node and the Type node are identical to the ones used in training (Figure 38) and 





Ensemble Model Training  
 The Ensemble node combines results of predictions for the target variable (I100) from 
the five trained models (Bayesian Network, Neural Network, Random Forest, Logistic 
Regression, CHAID) and generates a field containing the aggregated results. The 
Ensemble training results were observed by connecting the Ensemble node to the 
analysis node. It can be seen that the Type node is connected to only one model nugget 
(Bayesian Network). This is because the data types of the variables are fetched from the 
first model nugget (Bayesian Network) and then passed to the other four model nuggets 
followed by the Ensemble node. In Figure 38, the Type node was connected individually 
to the five data mining model nuggets, as each model fetched the data types of  variables  
independently. 
Ensemble Model Testing 
The Ensemble model testing is very similar to that for the other five algorithms (Figure 
41). The only difference is that instead of connecting individual model nuggets to the 
output table, the five model nuggets are connected to each other and then to the 
Ensemble node. This node is then connected to the Table node which generates the 
aggregated results. These results are evaluated for accuracy by comparing with existing 
data. 





4.2.4 Analysis of Results 
 
The results generated for the five base algorithms and Ensemble were evaluated for 
accuracy using the process described below: 
 The results from the output table for all testing models (Figure 41 and Figure 43) were 
pushed into the diabetes database. Since this table did not contain the target variable, it 
was added using a SQL query. The predicted column and the existing target variable 
information was compared for each row and the statistical accuracy of predictions was 
computed as follows: 
               =
                              
                                 
 
 For instance, the number of accurate predictions for I100 (testing dataset) using 
Bayesian Network was 3,976. The total number of values in the testing dataset was 4,765 
which gave an accuracy of 83.4%. Similarly, the accuracy was calculated for the 
remaining algorithms for all target variables (I100, I500, N179). 
It was also observed that the accuracy of predictions for all algorithms was consistently 







Figure 44 Predictive Modeling - I100 Results 
Figure 44 shows the accuracy of the trained models for target variable I100 with a total of 
4,765 patients. Ensemble and Logistic Regression had the highest accuracy for predicting 
patients with or without I100 (hypertension). Both these algorithms recorded identical 
accuracies of 84.15%. Bayesian Network, CHAID, Neural Network and Logistic 
regression made accurate predictions for 3,976, 3,979 and 4,003 patients, respectively, 
giving an accuracy as shown in Figure 44. The low accuracy (81.7%) of Random Forest 
can be attributed to overfitting problem which is one of the drawbacks of this algorithm. 
This dataset has 83% patients without hypertension and 17% (796) patients who were 
diagnosed with I100 (hypertension). For patients without hypertension, the six algorithms 
have an average accuracy of 97.2%. However, the average accuracy for those with 
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hypertension is only 15%. The reason for this low accuracy is the small number of patients 
in this group for the training dataset.  Specifically, there were 2,656 patients with 
hypertension which is only 18.9% of the total patients (14,016). This is the reason for 
70:30 split of the testing and training datasets of the total (2,656) patients diagnosed with 
target variable I100.  A smaller number of patients in the training dataset would have 
resulted in an even lower accuracy. The chosen distribution also ensured that both 
training and testing datasets contained patients in proportion to the entire database. 
Figure 45 Predictive Modeling - I500 Results 
Figure 45 shows the accuracy of the trained models for target variable I500 (Congestive 
Heart Failure) for a total of 4,959 patients. Ensemble recorded 92.61% accuracy followed 
by Neural Network with 92.57%. Logistic Regression, Bayesian Network and CHAID had 
104
accuracies of 92.5%, 92.5%, and 92.3%, respectively.  There were 415 (70%) and 970 
(30%) patients diagnosed with I500 in the training and testing datasets, respectively. 
These datasets were used for all six algorithms. The average accuracy to predict patients 
with and without congestive heart failure was 29.1% and 98.7%, respectively. As 
explained earlier, the smaller number of patients in the training dataset for this group 
(patients diagnosed with I500) contributed to the low accuracy. It is to be noted that 
diagnosed I500 patients were only 9.8% of the total number of patients (14,016) in the 
entire database. 
Figure 46 Predictive Modeling - N179 Results 
Figure 46 shows the overall accuracy of all algorithms for target variable N179 (Acute 
Renal Failure). CHAID and Ensemble had accuracies of 96.77% and 96.74%, 
respectively followed by Logistic Regression with 96.55%. Random Forest and Neural 
Network recorded an identical accuracy of 96.37% and Bayesian Network had an 
accuracy of 96%.  Within the database, there were a total of 1,303 patients who were 
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diagnosed with N179; these patients were split into training and testing datasets in the 
ratio of 70:30.  The average accuracy for predicting patients with and without N179 is 
63.7% (Figure 47) and 98.8%, respectively.  It was observed that CHAID had the highest 
accuracy of 67.7% followed by Ensemble with 66.4%. Bayesian Network, Logistic 
Regression and Neural Network had accuracies of 63.8%, 63.6% and 61%, respectively. 
For reasons mentioned earlier, Random Forest had the lowest accuracy (59.7%) for 
predicting patients diagnosed with N179. 
 
 
Figure 47 Predictive Modeling Accuracy for Patients with N179 
 
It was observed that as the percentage of patients for a target variable decreased, there 
was an increase in accuracy of predicting true positives across all algorithms. Since, N179 
had the lowest percentage of diagnosed patients, it had higher accuracy for predicting 
true positive cases. 
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4.2.5 Analysis of Variables 
 
 
Figure 48 Predictive Modeling using Feature Selection (I100, I500, N179) 
Figure 48 shows the predictive models using Feature Selection (FS) algorithm for the 






Figure 49 Feature Selection Results (I100, I500, N179) 
The dataset used was identical with the exception of target variables. It can be observed 
that the diagnosis codes E1152, E1164, E119 and E149 were identified among the top 
ten variables consistently for all three target variables. This can be attributed to the large 
number of patients diagnosed with these codes (Table 7). It can be seen that I100 is also 
included as one of the top three important variables for predicting I500 as well as N179.  
108
Codes E119 and E149 consistently rank outside the top five variables. These two codes 
specify diabetes patients without mention of complications which indicates that the 
probability of these patients to be diagnosed with other comorbidities is relatively low. 
45% of patients diagnosed with E119 and 38% of patients diagnosed with E149 had no 
other comorbidities recorded in this dataset. In contrast, 16% of patients diagnosed with 
E1152 and 14% of patients diagnosed with E1164 had no other comorbidities recorded.  
On further analysis, it was observed that 75% of E119 patients and 78% of E149 patients 
did not have either of I100, I500 and N179.  Similarly, 49% of E1152 and 39% of E1164 
patients were diagnosed with at least one or more of the three comorbidities (target 
variables) resulting in both of these codes to be ranked in the top five. An additional 
observation was that only two percent of the patients included all three target variables in 
their diagnosis. This is the reason N179 or I500 does not rank as important variables 
while predicting the others. The other variables such as Facility Name and Facility Health 
Service Delivery Area also show up as important because a majority of patients in this 
dataset were admitted to University Hospital of Northern British Columbia in HSDA 
‘Northern Interior’.  
The average age of patients in the dataset was 63 years and the average Total Length of 
Stay was seven days. Both of these variables were ranked as important. Though 
Physician Code was listed as one of the top ten variables, there was no substantial 
relationship found by FS with any of the target variables. The other diagnosis codes were 
not listed as important as they all had a lower percentage of diagnosed patients. 
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Table 7 Top Seven Diagnosis Codes 
 
 
4.2.6 Diabetes Comorbidities Assessment Tool 
 
A physician-friendly, interactive web form has been built to predict the likelihood of a 
patient to be diagnosed with one of the three comorbidities (I100, I500, N179) in future. 
An example for predicting I100 (hypertension) using this tool is shown in  
Figure 50 (input) and Figure 51 (output). The user input is given for all input variables 
excluding I100 which is the target variable. The Field column lists the input variables, the 
Storage column shows the data type, and Values column is where the user enters the 
input. It is to be noted that all string values need to be entered in double quotes and 
storage type is different from the data type of the variables which was explained earlier. 
Executing this web form runs the model in the background and generates output shown 
in Figure 51. The Ensemble algorithm is used in this case because it had the highest 
Code  Diagnosis Description Patients 
E119 Type 2 diabetes mellitus without (mention of) complications 7,956 
E1152 Type 2 diabetes mellitus with certain circulatory complications 3,763 
I100 Benign hypertension 2,656 
E149 Unspecified diabetes mellitus without (mention of) complication 2,105 
E1164 Type 2 diabetes mellitus with poor control, so described 1,674 
I500 Congestive heart failure 1,385 
N179 Acute renal failure 1,303 
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accuracy for predicting I100 among all six algorithms. The web form can be connected to 









Figure 51 Diabetes Comorbidities Tool - Output for I100 
Figure 51 shows the output which contains the I100 diagnosis and prediction probability 
for a patient with specified history. For example, a predicted value of 1 indicates that the 
patient will have hypertension in future, and there is a probability of 64% for this to 
happen. This patient was diagnosed with multiple comorbidities, which included the other 
two target variables (I500, N179). This can be the reason for a high probability of 64%. 
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The prediction was in conformance with the actual data of this patient (11219) who was 
in fact diagnosed with hypertension. Similar assessment tools were built for other two 
target variables (I500, N179) using the Ensemble algorithm. 
4.2.7 Summary 
 
In the above experiments, an interesting observation was that a decrease in percentage 
of diagnosed patients for a target variable leads to an increase in predicted values for the 
corresponding patient groups.  For example, I100, I500 and N179 had 18.9%, 9.9% and 
9.3% of the total patients, respectively with average prediction accuracies of 83.5%, 
92.4% and 96.5%, respectively. The reason is that the algorithms are able to train the 
models better when there is a lower number of patients. I100 and N179 had the highest 
(2,656) and lowest number of patients (1,303) with average corresponding accuracies of 
15% and 63.7% when predicting their respective diagnosis. 
It is observed that all algorithms perform relatively similar for each of the three target 
variables due to the following reasons: 
· Auto Classifier node was used to identify the data mining algorithms with high 
accuracies for all three target variables. 
· As mentioned in Chapter 3, only the important variables identified by FS algorithm 
were selected as input variables and passed to the models. 
· All twenty diagnosis codes had binary data (0,1) which included the target variable 
that helped the five classification algorithms to make efficient predictions. 
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 It is also to be noted that, Random Forest occasionally suffered from overfitting problem 

















Chapter 5  
Conclusion and Future Work 
Diabetes is a chronic disease whose prevalence is growing at a rapid rate throughout the 
world. It has also been called the biggest epidemic of the twenty-first century. The number 
of people with diabetes rose from 108 million in 1980 to 422 million in 2014 [53]. The 
global prevalence of diabetes among adults over 18 years of age rose from 4.7% in 1980 
to 8.5% in 2014 [1] . In Canada, one person is diagnosed with diabetes every three 
minutes, and one in ten deaths are attributed to this disease. Due to this prevalence, it 
has received global attention and vast amounts of data has been collected. Unfortunately, 
this data exists in disparate repositories and has not been harnessed to its full potential. 
However, it is now a well-known fact that diabetic patients must monitor their health 
constantly because of a higher risk of developing additional comorbidities over time. 
 Hypertension and Acute Renal Failure have been found to be among the top four 
comorbidities (Figure 52) [54]. Diabetes Canada [55] also reported that in almost every 
clinical trial one third of the patients with Heart Failure also had diabetes. Additionally, 
Heart Failure occurs in diabetic patients at an earlier age at a rate which is two to four-
fold higher in comparison with non-diabetic patients [55]. An early intervention and 
effective management is desirable to identify patients during the early stages of the 
disease. To this end, there have been efforts towards developing predictive models and 
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assessment tools for improving quality of life and reducing burden on the healthcare 





Figure 52 Comorbidities for Hospitalized Diabetic Patients in Canada [52] 
 
One of the key shortcomings of existing research is the use of non-clinical data which is 
collected using surveys and self-administered questionnaires. The dataset used for this 
research was obtained from Northern Health which exclusively comprised of diabetic 
patients with either T1D, T2D or any other types of diabetes between the years 2012-
2018. While this data contained only clinical records, it existed in the form of spreadsheets 
which made it difficult to analyze across a variety of parameters. In order to make data 
valuable for physicians and other stakeholders, several Key Performance Indicators 
(KPIs) were identified which provided insight into historical trends and patterns for using 
visual analytics. These metrics were presented in a visually appealing dashboard and 
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data was mined for predictive analysis. The developed models were then incorporated 
into an interactive assessment tool. 
This research had two major contributions. First, Predictive models were developed to 
find the likelihood of one or more of three comorbidities - Benign Hypertension, 
Congestive Heart Failure or Acute Renal Failure using six algorithms. The model results 
were incorporated into a physician friendly assessment tool which is flexible to be 
connected to one of the six algorithms to predict diagnosis and likelihood of one of the 
three comorbidities. Results from the assessment tool can act as an effective guideline 
for healthcare professionals to identify high-risk diabetic patients thereby ensuring 
effective diabetes management to reduce costs on the healthcare system.  Second, an 
interactive diabetes dashboard was developed to show an overview of the current state 
of diabetes for the years 2012-2018 in Northern Health. This dashboard was built with 
drill down capabilities to view aggregated results at finer granularities for various 
demographics (HSDA, LHA and Diagnoses). This research used a dataset specific to 
Northern Health facilities with majority of patients from Northern BC. However, both the 
dashboard as well as the predictive models have the capability to be extended to other 
regions and provinces which would reflect on the assessment tool as well. 
 
Diabetes Dashboard 
The dashboard was built using the Microsoft BI tool stack with provisions for integrating 
with diabetes dataset.  The dashboard consists of three top-level reports. First, the main 
dashboard displays overall statistics for 14,021 patients who recorded 34,824 admissions 
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in various Northern Health facilities. Second, a diabetes comorbidities dashboard 
identified the prominent comorbidities for these patients. Third, a HSDA comparison 
dashboard provides overall statistics for the three HSDAs – NE, NI and NW. These top-
level reports have drilldown capabilities to view reports at finer granularities. Several 
observations were made from these reports. For instance, it was interesting to note that 
51% of the patients had been diagnosed with between two to five comorbidities in addition 
to diabetes. The three selected target variables (I100, I500, N179) were among the top 
ten most prominent diagnosis codes recorded in the NH dataset. There was a consistent 
decrease of new diabetic patients from 2012 to 2017 with a slight increase observed in 





Patients diagnosed with diabetes can develop several other diseases over time. In this 
research, the focus was on identifying diabetic patients who are at a higher risk of being 
diagnosed with one or more of the following common comorbidities: 
· I100 (Benign Hypertension) 
· I500 (Congestive Heart Failure) 
· N179 (Acute Renal Failure) 
The reason for choosing these comorbidities was the large number of patients in the 
dataset who were diagnosed with at least one of these codes. For instance, there were 
approximately 19% of patients diagnosed with I100 (Hypertension). The other two target 
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variables I500 (Congestive Heart Failure) and N179 (Acute Renal Failure) also ranked 
among the top seven diagnosis codes with highest number of patients. Thus, these codes 
provide a good representation and also demonstrate how other comorbidities can be 
added to the study. Similarly, there are a number of data mining algorithms which are 
available in SPSS modeler. The following six representative algorithms were chosen to 
build our models: 
· Bayesian Network 
· Neural Network 
· Random Forest 




These six algorithms were evaluated for accuracy for the three target variables and 
analyzed. The important input variables for each target variable was determined by a 
built-in Feature Selection (FS) algorithm. It was observed that a decrease in the number 
of patients for target variables resulted in an increase in the accuracy of all algorithms. 
Another interesting observation was that Random Forest had a lower accuracy due to 
overfitting. Overall, an accuracy of 83.5%, 92.4% and 96.5% was observed for I100, I500 
and N179, respectively.  
Finally, a Diabetes Comorbidities Assessment Tool was built which took input from the 
user via an interactive web form and predicted the likelihood of one of the three target 
variables.  This tool is flexible and can be connected to any one of the six algorithms to 
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predicts the probability of a patient to be diagnosed with one of the three comorbidities in 
future. 
 
5.1  Future Work 
 
The work presented in this thesis has demonstrated the importance of visual and 
predictive analytics using clinical data. However, during the process several challenges 
were encountered and a wish list for further work evolved. One of the characteristics of 
the NH diabetes dataset was that the diabetes diagnosis codes were combined with other 
comorbidities. For example, diagnosis code E1123 represents patients having “Type 2 
diabetes mellitus with established or advanced kidney disease”. It would be more 
desirable to have an exclusive code for recording the type of diabetes (T1D, T2D, etc) 
and separate the comorbidities diagnosis of the patients.  This can make it easier to 
segregate patients with different type of diabetes and find out specific comorbidities of 
patients as well. Since majority of patients in the dataset are diagnosed with T2D, it would 
be interesting to create dataset with only T2D patients and run the existing models for all 
three target variables.  These results have the potential to reveal interesting correlations 
which are specific to T2D patients and can help healthcare professionals as well as 
patients to have a better understanding of their specific comorbidities. 
The three selected target variables (I100, I500 and N179) had relatively fewer number of 
diagnosed patients in the dataset which lead to reduced accuracy in predictive modeling 
for those group of patients.  It would be helpful to combine different diagnosis codes with 
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help of a Physician to increase the number of patients in these groups. For instance, the 
word ‘Heart’ is there in thirty-five diagnosis codes and ‘Hypertension’ was found to be in 
seventeen diagnosis codes. If all or at least, some of these codes can be combined, it 
would increase the number of diagnosed patients for the corresponding target variables. 
This increase of patients would reflect in the training dataset which can help enhance the 
accuracy of the models.  
Another recommendation would be to use the six algorithms for predicting the three target 
variables and only choose the important variables identified by FS as shown in Figure 49. 
This would eliminate some of the diagnosis codes which were included earlier.  This could 
potentially produce interesting comparative results on the performance of predictive 
models. 
It would be interesting to capture patient migration between communities and connect it 
with admissions and number of patients in the corresponding facilities over the years.   
Finally, adding time dimension to the metrics could allow a longitudinal study which could 
also predict the timelines when a comorbidity is likely to occur.   
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